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To Rochelle, Abigail and Adam 
In the beginning God created the heaven and 
earth. Now the earth was unformed and void and darkness 
was upon the face of the deep; and the spirit of God 
hovered over the face of the waters and God said "let 
there be light". And there was light. And God saw the 




The initial use of optical fibres to transmit laser energy 
intravascularly was accompanied by a high rate of perforations and the 
production of inadequate vascular channels when used for 
recanalisation. The laser thermal probe - in which all laser energy is 
converted into heat by a metal cap at the tip of the fibre, prior to 
tissue application - was one of the earliest modifications designed to 
overcome these problems. 
The studies in this thesis were concerned with the application of the 
laser thermal probe to percutaneous peripheral and coronary artery 
angioplasty and His bundle ablation. In vitro studies were commenced in 
March 1987 when the first (argon) laser generator was installed in the 
cardiac catheterisation laboratory at Guy's Hospital and these were 
followed by clinical studies in three groups of patients: nine with pe-
ripheral artery occlusions, three with coronary artery stenoses and 
four with supraventricular arrhythmias using either argon or Nd-YAG 
energies. 
Suggestions that enhanced safety might be possible with on-line 
monitoring and/or control of the probe temperature were studied by re-
cording the temperature responses in simulated circulations at flow 
rates observed clinically. The highly variable temperatures recorded in 
blood indicate that these measures are unlikely to contribute to im-
provements in either efficacy or clinical safety. 
An earlier report of successful peripheral artery recanalisation using 
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the laser thermal probe was confirmed in the patients studied here, 
though a learning curve was evident. Coronary laser angioplasty had 
also been performed in a few patients with a similar device but without 
as much success. A more flexible "over the wire" laser probe was as-
sessed here, first in cadaver coronary arteries and then in three pa-
tients undergoing coronary angioplasty. The lack of success seen with 
this laser thermal probe relates to the considerable differences found 
between peripheral and coronary arteries: percutaneous accessibility, 
vessel size and the susceptibility to thermal injury being the most im-
portant. These aspects and subsequent developments in coronary laser 
angioplasty are discussed further. 
The final chapter considers a hitherto new area for laser thermal probe 
application the interruption of arrhythmia circuits. Cadaver and 
electrophysiological studies indicated that ablation of the bundle of 
His might be possible with this device - without the need for a general 
anaesthetic. The course of the first patient ever to undergo this pro-
cedure is described, as well as the implications for percutaneous His 
bundle ablation using other energy sources. 
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Patients with coronary artery disease who do not have incapacitating 
symptoms nor adverse prognostic factors are usually satisfactorily man-
aged with medical treatment alone. The remainder however, usually re-
quire invasive therapy including coronary artery bypass grafting or 
percutaneous transluminal balloon coronary angioplasty and both proce-
dures carry high initial success rates. Coronary artery bypass graft-
ing is limited by graft failure (both early and late) and difficulty in 
adequately revascularising distal lesions and smaller vessels. 
Percutaneous balloon angioplasty is primarily limited by the inability 
to cross and dilate certain lesions ( occlusions and very tight 
stenoses) and has a recurrence rate approaching 30%. In addition there 
is a small incidence of periprocedural acute vessel closure due to se-
vere endovascular trauma. In peripheral artery disease percutaneous 
transluminal angioplasty has come to play an increasingly important 
role - to the extent of replacing bypass surgery in a large number of 
patients. Its ability to successfully treat long occlusions is however 
limited and these lesions also carry a high recurrence rate. 
Management of intractable or life threatening arrhythmias often re-
quires open chest cardiac surgery or percutaneous intracardiac catheter 
direct current ablation. During both of these procedures depression of 
conduction may occur (anaesthesia and manipulation of surgery and 
"stunning" during the electrical shock) so that the efficacy may only 
be determined some hours to days after the procedure with occasional 
suboptimal results. Direct current ablation avoids the invasiveness of 
the open chest procedures, but uses large amounts of energy which is 
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not deposited discretely. Cardiac chamber rupture, late ventricular 
dysfunction, arrhythmias and sudden death may result, probably due to 
the high intracavity pressure effects. His bundle ablation may be less 
susceptible to the serious side effects of intracavity shocks but also 
has a failure rate of up to 30%. 
The attraction for using laser energy in these situations is the poten-
tial for delivering concentrated energy very accurately to specific 
targets in order to create a precise effect. Of major importance is the 
ability to use a percutaneous non-surgical approach. Vaporisation of 
atheromatous obstructions rather than leaving them in situ (bypass 
grafting) or merely stretching and splitting them (balloon angioplasty) 
would be a major advance. Arterial obstructions that are currently im-
passable to the balloon may be able to be dilated once the laser has 
created a new intravascular channel. Distal lesions could be vaporised 
and help to complete revascularisation. Perhaps the most promising 
role for the laser in this setting would be to initially "debulk" 
larger lesions allowing more controlled balloon dilatation with fewer 
acute occlusions and late recurrences. Against these advantages the 
dangers of perforation, spasm and thrombosis, need to be evaluated. In-
terruption of pathological arrhythmia circuits might also be accom-
plished by creating highly specific lesions though at a risk of cardiac 
perforations and arrhythmias. 
A high incidence of complications and poor overall results attended the 
early clinical studies with conventional fibre optic delivery of laser 
energy leading to a number of modified approaches. The laser thermal 
probe, consisting of an optical fibre for transmitting laser energy to 
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rapidly heat a metal cap at it's tip, offers a number of theoretical 
advantages. The probe is capable of being introduced from the periph-
eral vasculature in standard percutaneous fashion and manipulated to 
the required intra vascular sites. All the laser energy is converted 
into heat prior to tissue application and thus remains highly local-
ised. Previous investigators have shown this approach to be practical 
and effective in some peripheral artery occlusions but its clinical 
role remains to be defined. The studies in this thesis were directed at 
assessing the efficacy and limitations of the laser thermal probe dur-
ing percutaneous peripheral and coronary artery angioplasty and His 
bundle ablation and at measures that might enhance its safety. 
Chapter 1 serves as both an introduction to the use of lasers in 
cardiovascular diseases as well as a review of current progress, some 
of which occurred at the time that the studies in the succeeding chap-
ters were performed. Chapter 2 assesses the thermal responses of laser 
probes in artificial circulations and the relevance of monitoring probe 
tip temperature clinically. Chapters 3, 4 and 5 describe the clinical 
studies in patients with peripheral and coronary artery disease and 
supraventricular arrhythmias respectively as well as the relevant in 
vitro work. 
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1.1 HISTORICAL PERSPECTIVE 
(a) From light to laser 
While light and its major source the sun were long held in awe by many 
primitive peoples - indeed the sun was often deified and offered human 
sacrifice - it has only been in recent times that the exact nature of 
light has been elucidated. Recognised as a source of power and healing 
by the ancients - Archimedes attempted to ignite the sails of the ap-
proaching Roman fleet by reflecting the sun's rays with parabolic mir-
rors and the ancient Egyptians used sunlight to treat vitiligo - full 
exploitation of these effects has only been realised with the recent 
development of the laser ( 1-3). 
Seventeenth century investigators were able to confirm that light was 
an emission but could not decide whether it was of a particulate or 
waveform nature. The prevailing view changed as each set of ex-
periments emphasised one or other of these mechanisms. In 1905 
Einstein expanded on the quantum theory of Plank and recognised the 
dual nature of light which could behave either as waves or particles 
(photons) depending on the type of experiment. Spontaneous and random 
emission of light photons from excited (or high energy) atoms or mol-
ecules is normally balanced by absorption of those photons by atoms in 
the (predominant) low energy state. In 1917 Einstein theorised that 
stimulated emission might occur when a photon or quantum of light of 
the correct energy collided with an excited atom to release its energy 
as a photon of light ( 4). The stimulated photon would be of the same 
frequency and wavelength and most importantly be in phase with the in-
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cident photon. 
The first practical application of this theory was by Townes and his 
co-workers in 1953 who were able to amplify microwaves by stimulated 
emission after increasing the proportion of excited molecules ( "popula-
tion inversion") in ammonia gas. They coined the phrase "maser" an ac-
ronym for (m)icrowave C!:!)mplification by (~)timulated (~)mission of 
(!:)adiation (1). Shortly after Schawlow and Townes proposed the exten-
sion of this technology to include wavelengths in the visible spectrum 
(2): the 1 for (!)ight replacing the m in (m)aser. In 1960 the first 
stimulated emission of visible wavelengths was reported by Maiman using 
a solid block of ruby (the ruby laser) (3). 
(b) Medical applications of the laser 
Medical exploitation of the ruby laser was rapid. Ophthalmologists were 
the first to use the brief but intense ruby light pulses to create 
highly controlled retinal burns for repairing retinal detachments. 
Thermal damage to surrounding non-target tissues during the prolonged 
applications necessary with the conventional xenon photocoagulator and 
the need for anaesthesia were thereby avoided (5-8). The red ruby light 
was however not absorbed by red cells and its role was soon supplanted 
by the continuous wave argon laser (9) whose wavelength was more effec-
tive for vessel coagulation (10). Almost equally rapid was its applica-
tion to dermatology where argon light was found to be selectively ab-
sorbed by pigmented skin lesions (11-13). Research into its use for 
malignancies was also initially promising ( 14-17) . It was recognised 
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that the laser effects were primarily thermally mediated ( as was clear 
in ophthalmological use) though the intense delivery was thought to be 
beneficial ( 18). It became apparent however that the high intensity 
pulses resulted in debris being explosively ejected during the 
irradiation of tumours with dispersion of viable cells and it fell into 
disrepute as a treatment for cancer (19-20). In 1965 the CO2 laser 
which emitted infrared light in a continuous mode was developed ( 21) . 
The high power was delivered at a wavelength which was almost com-
pletely absorbed by water (and therefore also tissue water) so that it 
could be used to create precise surgical incisions. Initially used for 
middle ear surgery ( 22) the precision and blood coagulating effects 
were more usefully employed for laryngeal surgery ( 23) and then more 
widely in general surgery ( 24) , for excision of burns ( 25) , in gynae-
cology (26) and in neurosurgery (27). In the early 1970's the Nd-YAG 
laser (28) which had greater penetrating power but was also subject to 
considerable scattering in tissue was found to be transmissible via op-
tical fibres ( 29) . Shortly after both N d-Y AG and argon laser energies 
were used by gastroenterologists to induce haemostasis in bleeding ul-
cers at endoscopy (30-32) opening the way to further remote medical ap-
plications. Development of the dye laser (32) allowed a choice of spe-
cific laser wavelengths and this found use in dermatology ( 33) and 
ophthalmology (34). The most recently discovered class of lasers was 
the excimer ( = excited dimer - the active medium formed by a mixture of 
a halogen and rare gas) laser (35) emitting wavelengths in the ultra-
violet range of the spectrum with very high energy photons. These have 
been used for precise corneal sculpting that does not leave any detect-
able thermal damage along the incision margins ( 36) . 
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(c) Early cardiovascular applications 
During the early medical developments, laser technology was only curso-
rily directed to the cardiovascular system. In 1963 McGuff et al (in 
addition to their systematic studies of laser energy as an anti-tumour 
therapy) used the pulsed ruby laser to destroy cadaver artery plaque 
(14) but the extension of this idea was delayed for nearly two decades. 
Yahr and colleagues performed microvascular anastomoses with a 
neodymium-glass laser in 1964 (37) but little further work was done un-
til interest was renewed in 1979 (38) - though the technique is still 
not applied clinically to any important degree ( 39). Arapov and 
co-workers described the first cardiac application using a CO2 laser to 
assist intra-operative pulmonary valvotomy in 1974 with purportedly 
good results ( 40) though this work does not appear to have been ex-
tended. Finally in 1977 Mirhoseini used the CO2 laser to replicate 
Sen's technique ( 41) for direct myocardial revascularisation by creat-
ing channels between the myocardial sinusoids and the left ventricular 
cavity. Experiments in dogs were successful at preserving left 
ventricular function after coronary artery occlusion and the laser 
channels were found to remain patent for longer than Sen's needle 
acupuncture tracts ( 42). Performed as an adjunct to conventional 
coronary artery bypass grafting ( 43) obvious clinical benefit has not 
been apparent. Human myocardium does not have the extensive sinusoidal 
network seen in the canine myocardium and later studies have shown that 
even the laser channels do not remain patent for longer than two weeks 
(44). 
In 1980 Macruz and co-workers followed up on the initial atheroma stud-
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ies of McGuff but also used the laser for large and small vessel 
anastomosis, pulmonary valvotomy and mitral chordal shortening studies 
in animal models. Using both CO2 and argon energy they were able to re-
move atheromatous plaque (fibro-fatty and calcific) from cadaver aorta 
and showed that thermal damage was limited theorising that the 
"smooth" charred surface would not be thrombogenic. Laser lesions were 
created in dog femoral and carotid arteries which at later study were 
devoid of thrombus and showed re-endothelialisation. More importantly 
the group transmitted argon light via an optical fibre introduced into 
a cardiac catheter and were able to "repair" artificial "pulmonary 
stenoses" via a percutaneous approach. Using the same system they 
recanalised carotid artery stenosis preparations in dogs though also 
caused some perforations ( 45). At the same time Choy independently de-
veloped a similar approach ( 46) and using argon light transmitted via 
an optical fibre / catheter system was able to vaporise atheroma in ca-
daver coronary arteries ( 47). Choy and his co-workers then extended 
this work to disobliteration of human thrombi in dog and rabbit models 
(48). Subsequent in vitro (49-55) and in vivo animal studies (56-63) -
with a leading role played by Lee et al and Abela et al - confirmed the 
ability of laser energies to vaporise atheromatous and thrombotic vas-
cular obstructions. 
These encouraging reports led to the first percutaneous human 
revascularisation procedure by Ginsburg in 1983 in a patient with a 
subtotally occluded femoral artery and threatened leg amputation (64). 
Shortly thereafter Choy attempted intra-operative coronary 
revascularisation with the production of very small channels and one 
out of five perforations (65). At follow up all of the vessels were oc-
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eluded although competing flow from the concomitant saphenous venous 
grafts was thought to be partially responsible. Subsequent series of 
peripheral artery ar.gioplasty were disappointing - small channels and 
perforations being the predominant problem (66,67) - and modifications 
to the basic "bare fibre" laser approach began to be explored. While 
this early work was in progress laser energy also began to be investi-
gated for use in ablation of ventricular arrhythmogenic foci (68-70) 
and the bundle of His ( 71, 72), atrial septostomy ( 73), relief of con-
genital pulmonary and aortic stenoses (74) and coarctation of the aorta 
(74, 75), myoplasty in hypertrophic cardiomyopathy (76) and even de-
calcification of adult stenotic aortic valves (77, 78). 
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1. 2 BIOPHYSICS OF LASER ENERGY 
(a) Laser physics 
Lasers may be described by the nature of the active medium, the precise 
wavelength of light emitted, by their mode of action and their power 
but certain basic features are common ( 79-81). All lasers consist of an 
active medium, an excitation mechanism, and a pair of mirrors surround-
ing the active medium. The active (or gain) medium in which the laser 
action occurs may be in a solid, a gas or less commonly a liquid state. 
The excitation mechanism ( or power source) which raises the energy 
state of the active medium varies and may be an electrical currents 
(solid state or gas lasers), a flash lamp (solid or liquid state la-
sers) or indeed another laser (solid or liquid state lasers). The 
light emitted from molecules in the active medium propagates itself 
through the medium and photons in the long axis are repeatedly re-
flected between the two mirrors at either ends recruiting further pho-
tons. The one mirror is totally reflective but the second is partially 
reflective allowing a controllable amount of laser light to exit the 
cavity through it. Laser light is monochromatic (of a single wave-
length) and coherent (the light waves are in a single phase and in the 
same direction) and it is these two properties which contribute to the 
intensity of the output. 
The power output of the laser is dependent on the specific active me-
dium itself, the amount of power input by the excitation mechanism and 
the length of the active medium chamber. In general solid state lasers 
are far more compact than gas lasers which require a long chamber to 
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amplify the power to similar levels . The spectrum of light emitted 
from a laser is a function of the active medium molecules ( representing 
the change in energy states) and is usually restricted to a few dis-
crete wavelengths (e.g. CO2 = 10.59 um; Nd-YAG = 1.06 um; Argon = 488 
and 514.5 nm; Xe-Cl= 351 nm). Electronic and optical mechanisms may be 
used to select or reject a particular wavelength/ s. It is also pos-
sible to double or triple the frequency of the original light by pass-
ing the output through a non-linear crystal and recombining the laser 
beam with itself though this entails a loss in the power output. The 
liquid state, dye lasers emit a broad band of wavelengths which can be 
"tuned" with an optical selection mechanism so that a range or specific 
wavelengths within the band can be obtained. 
The mode of action of lasers is determined by the manner in which the 
excitation energy is delivered or "pumped" to the gain medium. Con-
tinuous wave lasers are driven by a constant source of energy (such as 
an electric current) passing through the medium and replenishing energy 
lost as laser discharge through the mirror. In some lasers the active 
medium is only able to be excited by a sudden rise in energy producing 
a brief laser emission and then returning to the non-energized state. 
These pulsed lasers may be driven by flash lamps or high voltage elec-
tric discharges and the resultant energy output is far greater than 
continuous wave lasers (mega - kilowatt range vs <100 watts). The 
greater peak instantaneous powers however are only short-lived (nano 
microseconds) although may be efficiently repeated at rates that are 
dependent on the pumping mechanism. In contrast the continuous wave 
lasers whilst able to produce a continuous output are rather in-
efficient in the utilisation of the power source. 
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(b) Biological effects of laser energy 
Absorption by tissue molecules of the incident photons is the basis for 
any laser effects. Not all light is absorbed and depending on the opti-
cal properties i.e. wavelength, some may be reflected or transmitted to 
deeper tissue planes. Scattering of transmitted light within tissue 
leads to an increase in the irradiated volume and the extinction of the 
incident light is thus a function of both absorption and scattering 
(82,83). Absorbed photons will raise the energy levels of the molecules 
with either conversion to chemical energy (photochemical effects), 
emission of a lower energy photon (fluorescence) and/or conversion to 
heat. More complex effects include shock waves generated by thermal ex-
pansion, molecular bond disruption by very high energies and laser beam 
induced optical changes increasing the focusing of the beam in the tis-
sue (18,84) 
The rise in temperature and any damage depends on 1) the optical prop-
erties of the light (principally wavelength and colour-related absorp-
tion) , 2) the irradiance parameters ( laser power, beam diameter and ir-
radiation or exposure time) and 3) thermal properties of the actual 
tissue (specific heat, conduction and thermal relaxation time and the 
rate of blood flow) (85). 
Temperatures up to 55-60 °c cause reversible coagulation of protein but 
are tolerated for only brief periods. At greater temperatures irrevers-
ible denaturation occurs with shrinkage of collagen. The degree of 
collagen shrinkage is proportionate to the tension applied to the tis-
sue; veins perfused with heated blood shrink at 70 °c while arteries do 
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so at temperatures of 75 °c (86). At these temperatures thrombus forms 
as the heat coagulated red cells initiate platelet aggregation (87 ,88). 
The combination of shrinkage and thrombosis is sufficient to obliterate 
vessels up to 1. 0 mm in diameter but larger vessels require, in addi-
tion, pressure to appose the thermally coagulated walls allowing "weld-
ing" (89). At 100 °c tissue water begins to boil with great expansion 
in volume and explosive disruption of cell walls liberating steam ( "va-
pour trails") . Residual cell matter experiences a rise in temperature 
only once all cellular water has evaporated and tissue vaporisation 
(i.e. conversion to gaseous products) occurs at temperatures in excess 
of 160 °c (90-92). At temperatures in excess of 300-400 °c carbonisa-
tion of solid material occurs. During this process heat is also con-
ducted to surrounding tissue which will undergo changes according to 
the temperature attained. The rate of temperature rise is dependant on 
the thermal conductivity of the neighbouring tissue but is also 
critically dependent on the rate of energy delivery (93). In general 
where the rate of energy delivery is high there is less time for ther-
mal conduction to occur and the surrounding area is less affected 
( 94, 95) . Where absorption is high ( and scattering low) localised ef-
fects are also more apparent. 
28 
( c) Cardiovascular effects of laser energy. 
( 1) Continuous wave lasers 
It soon became apparent that the commonly used continuous wave lasers 
( co2 , argon and N d-Y AG) ablated atheroma by a similar thermal process 
(51). Both normal vessel and atheroma subjected to continuous wave en-
ergies demonstrated a crater of variable depth from which tissue had 
been removed and this was lined with a layer of charred material. Im-
mediately adjacent to this was a second zone of polymorphous lacunae or 
vacuoles (49,51,57,59,96-99). Initially thought to represent "acoustic" 
injury from "shock" waves produced during vaporisation (51) they are 
now considered to represent expansion of gasses from boiling cells or 
nuclei (96). Beyond these vacuoles was a third zone of oedema, collagen 
shrinkage and coagulative necrosis of cells (manifested by 
hypereosinophilic staining) gradually merging with the undamaged tis-
sue. The extent and depth of damage increased with increments in the 
power or duration of application and seemed to correlate best with the 
total energy delivered ( 51). This was at variance with previous 
non-cardiac studies ( 94, 95) and later studies revealed that delivery 
of energy over very short intervals reduced the thermal injury zone ad-
jacent to the crater compared to identical energies delivered over a 
longer interval (96,100). Arterial wall appeared to be more resistant 
to thermal injury than (non-calcific) atheromatous plaque (101,102). 
The effects on cardiac tissue were similar but the extent of damage 
differed. For the same amount of energy more extensive damage occurred 
in myocardium than elastic or muscular arteries ( 97) while calcified 
valves demonstrated the greatest amount of charring (78). Shortening of 
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chordae tendiniae and valve cusps occurred with even subperforative in-
jury ( 45, 97) . Analysis of gaseous products from all tissues revealed 
typical thermal combustion degradation products (103). During the va-
porisation process cellular water was converted to steam, and the re-
maining matter thermally combusted producing water vapour, carbon mon-
oxide and light hydrocarbon gasses, dissolved protein fragments and 
heterocyclic nitrogenous compounds, and solid carbon particles and cel-
lular debris (103,104). Analysis of the non-filterable debris after ab-
lation of atheroma and thrombus rarely reveal particles greater than 
9. 37 um (104,105) and recognised or important embolism appears to be 
infrequently recorded clinically and experimentally ( 106). 
Much of the early work was performed with an air-tissue interface so 
that energy parameters were not readily applicable in vivo unless a dry 
bloodless field could be created. As was apparent from non -cardiac 
use, CO2 energies produced the least penetrating craters while Nd-YAG 
produced the most extensive damage with considerable subdjacent thermal 
coagulation ( 79-81). Rate of flow and the specific optical and thermal 
properties of saline or blood dramatically influenced the tissue ef-
fects. CO2 energy effects were markedly attenuated in saline or blood 
(being highly absorbed by the water content) at depths of 2. 9 and 30 um 
respectively (82,107). Despite the considerable attenuation by water -
in small volumes and depths of saline, heating of the saline may lead 
to typical thermal lesions. Difficulty in transmitting CO2 energy with-
out heat loss over non-toxic optical fibres has limited its cardio-
vascular applications: a single report of successful intra vascular 
transmission has not been developed any further (108). Clearly defined 
planes can be developed in "dry" fields and in one centre it has been 
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found to be effective for intra-operative coronary endarterectomy using 
a hand held wave guide (109). Argon light is strongly absorbed by 
haemoglobin so that there is limited transmission through blood. In 
stationary blood the divergence angle increases to 30° (15° in saline) 
with less forward projection yet the tissue effects are greater with 
wider and deeper craters than in saline. During energy delivery gas is 
liberated anc it is assumed that the blood itself is heated (and vapor-
ized) indirectly heating the tissue (110). In contrast with flowing 
blood little damage occurs presumably due to lower absorption by each 
volume of blood and therefore less transmission of heat to the tissue. 
Nd-YAG energies are easily transmitted through blood but again the le-
sions are increased in its presence (stationary or flowing) when com-
pared to saline. While a gas bubble also forms at the tissue interface 
and may contribute to thermal effects (100), it has been postulated 
that charred blood attached to the crater is better at absorbing the 
light further increasing the local heating (51,111). Su perfusion with 
cold saline or blood attenuated the thermal effects of all lasers 
(51,100) by acting as a heat sink. 
Vascular healing after thermal damage has not been intensively studied 
but was on the whole favourable. Various animal studies including 
atherosclerotic models or those with human thrombus or vessel implanta-
tions have been studied and reveal the formation of a fibrin platelet 
plug followed by re-endothelialisation over the ensuing days. A de-
pressed area often remains with a degree of intimal thickening and 
chronic inflammatory cellular infiltrate. Re-endothelialisation is 
usually complete by two to four weeks after CO2 , argon or Nd-YAG 
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energies (57 ,59,60,112-114) although in a single canine femoral artery, 
healing was said to be complete five days after vaporisation of a 
thrombus ( 48). While acute perforations were not uncommon in these 
studies aneurysm formation was only reported in a small proportion of 
animals in two studies (atherosclerotic rabbit model and porcine ca-
rotid artery implanted into the aorta) ( 59, 60) . A comparison between 
balloon angioplasty and laser thermal effects in the atherosclerotic 
rabbit model revealed larger mean luminal diameters and less 
fibrocellular proliferation four weeks after the laser procedure ( 115) . 
Human atheroma is different to animal models and less encouraging was a 
report of persistent thermal damage without re-endothelialisation in 
two femoral arteries two to four weeks after initially successful 
laser/balloon angioplasty - although thrombus formation was absent at 
this time ( 116). 
( 2) Pulsed lasers 
Pulsed lasers such as the ultraviolet wavelength xenon chloride excimer 
lasers produce much greater peak powers though over very brief time in-
tervals. Histology of vessel subjected to pulsed excimer energy is re-
markable for the "clean" edges without charring or any of the other 
typical features of thermal injury (117-119). The high peak powers of 
excimer lasers have been postulated to have a non-thermal photochemical 
effect on the tissue causing disruption of chemical bonds but this is 
controversial (120). The energies used are theoretically enough to 
break chemical bonds, ejected fragments have a velocity greater than 
expected for thermal vaporisation and tissue temperatures are lower 
than those measured during thermal ablation (121). In addition if low 
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peak pulse powers are used or pulsed energy is unfocused ( and therefore 
effectively at a lower energy density) thermal damage may occur - the 
implication being that insufficient energy to break chemical bonds is 
delivered. The contrary view is that the effects are predominantly 
thermally mediated but that heat is able to disperse between pulses so 
that tissue temperature does not rise, craters show less charring and 
vacuolation and thermal coagulation is absent. Evidence to support this 
is the fact that lower energy visible and infrared wavelengths if de-
livered in a pulsed form e.g. Q-switched (an optical mechanism designed 
to briefly store and thus increase the gain medium energy) Nd-YAG or 
very high peak power CO2 lasers can produce identical histological re-
sults despite lacking the energy per pulse necessary for "photochemical 
disruption" (122). In addition if pulsed excimer energies are delivered 
for extended periods thermal damage is apparent implying that the ther-
mal diffusion capacity has been overwhelmed (123). Finally gas chro-
matography of degradation products is similar for both continuous and 
excimer lasers (124). Until recently the ability to transmit these en-
ergies without damage to the optical fibre has precluded the use of 
this energy intravascularly (125-127). Of interest was the paradoxical 
ability of pulsed CO2 and excimer energy to be transmitted effectively 
through blood even though absorption spectra of water ( co2) and haemo-
globin ( excimer) predict this is unlikely. This is thought to be due 
to a "Moses effect" (128) whereby pulsed energy creates an optical cav-
ity ("channel") caused by a true acoustic transient ( shock wave) - due 
to rapid thermal expansion of ( 129) the highly energised molecules. 
The theoretical advantages of using pulsed lasers to avoid thermal dam-
age adjacent to the vaporised area has not been demonstrated to have 
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clinical benefit to date. The repair process of the continuous wave en-
ergies is on the whole benign in animals (except for two reports of an-
eurysm formation) and in humans. The few studies performed using 
pulsed energies reveal a similar repair process with initial thrombus 
formation and re-endothelialisation but much less subjacent reaction 
(128,130-132). Of more importance is the demonstration that, in vitro, 
laser application produces vasoconstriction with continuous wave ener-
gies but vasorelaxation with pulsed energy ( or continuous wave energies 
too low to ablate the wall and raise the temperature) (133). In canine 
coronary arteries delivery of similar amounts of energy via continuous 
wave lasers has caused spasm that does not occur with pulsed energy 
(134). One study has however also recorded spasm with pulsed excimer 
energy in a rabbit model (135). 
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1.3 CURRENT STATUS OF CARDIOVASCULAR LASERS 
(a) Intravascular delivery of laser energy 
The ability to transmit large amounts of energy over distance (without 
significant loss) and concentrate it onto a small target area for a 
specific effect is the major attraction for using the laser in cardio-
vascular disease. Many different lasers have been explored in the 
cardiovascular system but none have been found to be ideal for any par-
ticular application. While the wavelength, power output and mode vary 
considerably with different lasers, these differences can only be ex-
ploited clinically if an adequate mechanism exists to conduct the light 
to the target tissue. For intra vascular application five separate com-
ponents need to be integrated: 
1. The laser source itself (wavelength, power, mode); 
2. An accurate coupling mechanism from the laser to 
3. Optical fibre/ s which can transmit the light via 
4. A catheter delivery system to 
5. A terminal energy delivery interface at the target tissue. 
The optical fibres used for intravascular laser energy delivery have 
major limitations when used in their simplest form for vascular 
recanalisation - i.e. as a fibre protruding from a catheter. The highly 
collimated beam of light emitted from the fibre is only able to create 
a neolumen fractionally larger than the fibre diameter itself due to 
the small degree of beam divergence. The largest fibres capable of 
intravascular delivery have a diameter of 600 um and are difficult to 
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manipulate except in straight segments of relatively large arteries. 
The smaller fibres ( <100 - 300 um) are more flexible and manoeuvrable 
but create correspondingly smaller channels. 
The optical fibres are radiolucent and thus difficult to position 
coaxially resulting in perforations - both mechanical from the sharp 
tips and thermal during energy delivery (60,62,63,66,67 ,112,113, 
136-138). This is particularly evident in the tortuous coronary arter-
ies, at branch points or when the plaque is eccentric (139), and under-
lines the insensitivity of fluoroscopy as the sole monitor of progress. 
The transition from atheroma to normal vessel is rarely sharply demar-
cated heightening the difficulties in measures designed to improved 
atheroma recognition and/ or selective ablation. Atheromatous deposits 
are heterogeneous in their composition which further detracts from easy 
recognition. Fatty and fibrous plaques are also more easily vaporised 
than calcified plaque which is only efficiently ablated by pulsed la-
sers (140). Attempts to displace blood to avoid absorption of the laser 
energy (balloon occlusion and/or saline flush) may be nullified by the 
presence of subintimal haemorrhage in a plaque which may still heat up 
excessively and perforate ( 141). In addition thinning of the media is 
well recognised with atherosclerotic disease (142) and indeed plaques 
may replace much of the vessel wall leaving only a thin layer of normal 
media/adventitia (143) narrowing the margin for total plaque ablation 
without perforation. 
The "ideal" laser system for treating obstructive vascular disease 
might thus include the following features: 
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1. A laser wavelength selectively absorbed by atheroma - and 
reflected or scattered by normal vessel. 
2. Localised atheroma vaporisation without adjacent tissue thermal 
damage during the ablation process. 
3. Efficient coupling and transmission via optical fibres that are 
non -toxic and flexible. 
4. A catheter delivery system that is both a traumatic and easily 
guided and manipulated. 
5. A tip design that allows delivery of sufficient energy for 
ablation to the necessary vessel diameter. 
6. An identification system for reliably distinguishing atheroma 
from the normal vessel wall - either laser based or external to 
the laser. 
Current strategies for maximising the effectiveness and safety of laser 
angioplasty will be discussed with reference to: 
1) Improvements in atheroma detection and selection 
2) Modifications to the distal tip of the laser 
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(b) Targeting the plaque 
Despite the imprecise transition between plaque and normal arterial 
wall attempts have been made at improving plaque uptake of specific 
wavelengths and plaque identification either before or during laser en-
ergy delivery. 
(i) Enhancement of atheroma ablation 
A number of studies have shown that the optical absorption, transmis-
sion and reflection characteristics of normal wall and atheroma are 
different (as are their thermal properties). Absorption spectra of 
normal and atheromatous wall show only very small differences with ar-
gon (144,145), pulsed Nd-YAG (111) and near ultraviolet wavelengths 
(146). While atheroma will absorb more energy at these wavelengths the 
ablation thresholds are not sufficiently different to utilise 
clinically (146). More recently a differential selectivity of 10-100 
fold has been found with pulsed wavelengths of 480-490 nm in saline 
(147). Enhancement of this process has been attempted by administration 
of exogenous substances that are taken up by plaque to a greater extent 
than the normal vessel. Preferential absorption has been shown at 631 
+/- 5 nm with haematoporphyrin derivative (148), at 355 nm with tetra-
cyclines (149) and at 465 nm with carotenoids (150). In the 
atherosclerotic rabbit model administered haematoporphyrin derivative 
the selectivity for atheroma was not enough to prevent both medial and 
endothelial damage after delivery of light dose rates far lower than 
were necessary to cause thermal ablation ( 151) or produced inconsistent 
effects (152). Orally administered carotenoids are selectively taken up 
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by atheroma ( 50 fold increase above normal levels) but in vivo effects 
of delivering 461 nm light are yet to be performed ( 153). 
(ii) Enhancement of atheroma recognition 
Fluorescent Spectroscopy: While selective plaque destruction appears 
difficult to attain due to the small absorption difference between 
atheroma and normal wall ( even in the presence of chromophores) recog-
nition of optical differences may be useful. Discrimination of atheroma 
from normal wall by induced fluorescent spectroscopy has been recog-
nised to be possible for some time (154-155) but the optimum wave-
lengths to be used clinically are not clear as yet. Leon et al using 
wide-band blue light demonstrated a fluorescent absorption intensity 
ratio of 2: 1 between normal and diseased vessel at 540 nm in vitro 
(156). Using a different approach, Deckelbaum et al found that fluores-
cent intensities were also able to discriminate between different mor-
phologies of atheroma: maximum intensities at 514 nm for normal; 448 
for fibrous atheroma; 538 nm for fatty plaque. Using this system in 
which the "normal" spectra falls "between" that of different types of 
atheroma would require analysis of the ratios of the three spectral in-
tensities (157). Further enhancing this approach is the preserved abil-
ity to perform fluorescent spectroscopy during laser ablation without 
distorting the spectral display so that the change to "normal" wall can 
be recognised (156,158). These differences and hence the diagnostic 
ability are likely to be further enhanced by the use of chromophores 
and this has been demonstrated by Prevosti et al using haematoporphyrin 
derivative (159). Surface fluorescent spectra at 631 nm could not 
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discriminate between normal and atheroma until sensitised with 
haematoporphyrin derivative. 
Non-laser: Simultaneous angioscopy has been used usually on an 
intra-operative basis to target the lesions prior to and to monitor 
progress during delivery of energy ( 56, 58,160). Even this approach has 
only met with limited success at avoiding perforations ( 101). Finally 
intra vascular ultrasonic delineation of the vessel diameter, wall 
thickness and constituents is being investigated but its impact on 
guiding laser systems is yet to be evaluated ( 161). 
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( c) Optical fibre modifications 
From the earliest studies of intravascular energy delivery it was ap-
parent that coaxial alignment was critical to avoid perforating the 
wall. Measures to enhance positioning included sheathing the fibres 
within radiopaque catheters, placing markers on the fibre tip and using 
steerable guide wires placed within the catheter alongside the fibre 
(162-163). An alternative approach to enable coaxial alignment was to 
support the fibre within an inflated balloon in the vessel (106,164). 
While these manoeuvres contributed somewhat to improvement of coaxial 
alignment they did not enhance the ability to create a larger lumen. 
Geschwind et al used an asymmetric balloon to align the fibre parallel 
to the wall but not in the centre of the vessel. By rotating the bal-
loon it was possible to create a larger lumen than if the fibre had 
been kept in a single plane ( 165). 
It was only after considerable fibre tip modifications, however, that 
it became possible to create a lumen substantially larger than the fi-
bre diameter. Paradoxically it was by deliberately "sacrificing" some 
of the intrinsic f ea tu res of laser energy (i.e. the finely focused beam 
and the direct laser tissue interaction) that finally allowed reliable 
clinical applications. 
( 1) Metal capped optical fibres 
The recognition that thermal mechanisms were the basis of 
recanalisation by all continuous wave lasers led to an approach de-
signed to maximise thermal transfer to the treated surface. The bare 
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fibre tip was encased in a metal cap (Fig. 1.1) which absorbed all the 
incident laser energy and then became rapidly heated ("hot tip") 
achieving temperatures in excess of 1000 °c for a 2. 0 mm tip in air 
(166). Lower temperatures were recorded in fluid or solid media with 
their greater heat dissipation capabilities (i.e. lower insulation) but 
these were sufficient to allow recanalisation of occluded arteries in 
vitro (167). 
The smooth oval tip avoided mechanical perforations while the localisa-
tion of the energy at the tip prevented laser beam perforations. In dog 
and atherosclerotic monkey models thermal lesions in coronary arteries 
were created without acute complications and there was no evidence of 
thrombosis on later follow up (168,169,170). The incidence of perfo-
rations was markedly reduced by comparison with bare fibre angioplasty 
using similar energy parameters in the atherosclerotic rabbit model 
( 171) . In addition the channels produced were much larger than those 
produced with bare fibres alone and this finding was confirmed during 
recanalisation of human coronary artery segments implanted into canine 
femoral arteries (168). Finally what was most encouraging was that the 
larger channels made in a rabbit model showed less restenosis than the 
channels found after balloon dilatation - confirmation for the first 
time that laser recanalisation might indeed be superior to balloon 
dilatation ( 115). 
An alternative version allowed 10-20% of the light to exit via a cen-
tral channel into which was set a small sapphire lens for an additional 
laser tissue interaction ( 101). In practise, however, this device func-
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LASER THERMAL PROBE 
Figure 1.1 Diagram illustrating the principle of the "hot tip" laser 
thermal probe. 
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These experimental results were confirmed in patients with long 
femoro-popliteal artery obstructions in many of whom conventional bal-
loon angioplasty had failed ( 173). The technique was then extended to 
patients with coronary artery disease though with a lesser measure of 
success (174,175). Further experience with this type of system is de-
scribed in the following chapters. 
(ii) Sapphire Tipped Optical Fibres 
When placed at the tip of an optical fibre the sapphire acts as both a 
lens to diverge the laser emission (usually Nd-YAG) while absorbing 
some of the light (+/- 50%) and heating up itself (176). The larger di-
ameter tip - up to 2. 2 mm - avoids the perforation problems of the bare 
fibre and recanalises by a combination of mechanisms i.e. direct laser 
tissue interaction and an indirect thermal mechanism as with the metal 
capped thermal probe. The larger channel produced by the divergent beam 
is further enlarged by thermal compression during passage of the tip 
and possibly by additional thermal ablation. The high temperature at-
tained by the sapphire requires a cooling system to prevent damage and 
the complexity of tip perfusion reduces the flexibility of the "probe" 
so that delivery to smaller tortuous vessels is difficult. Early in 
vitro and in vivo animal studies demonstrated a favourable 
recanalisation rate with a low failure/perforation rate (114,177,173) 
and clinical success in peripheral artery recanalisation has followed 
(179). 
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(iii) Optical Shields and Lenses 
The simplest modification to the optical fibre was to fuse the tip into 
a sphere of up to 1.2 mm ("glass ball tipped fibre") which increased 
the light divergence and whose smooth surface was less traumatic to the 
vessel wall (180). A preliminary report suggests that these are both 
safe and effective in vivo ( 181) . 
Another approach was to place an optical assembly containing a small 
lens at the end of the fibre. Divergence of argon light by the lens 
into a 40° cone, both limited the penetration to 2-3 mm while enlarging 
the beam size from the 200 um fibre, producing +/-2.0 mm diameter cra-
ters in vitro. The lensed fibre is passed through a vascular catheter 
which is flushed continuously to prevent blood entering the space be-
tween the lens and the fibre during in vivo use (182). 
Perhaps the most sophisticated assembly is the multifibre catheter of 
Cothren et al (183). A clear optical shield protects the 19 fibres (100 
um diameter) from blood or tissue contact. Fibre combustion during tis-
sue or blood vaporisation is thereby avoided, preventing distortion of 
the optical transmission characteristics of the individual fibres 
( 180). The beams of the fibres overlap so that the catheter can ablate 
its own diameter (2.5 mm) but the depth of thermal damage on the outer 
margin is only as wide as that seen with a single 100 um fibre. Suc-
cessful in vivo animal studies using argon energies have been performed 
recently (184,185). It is further envisaged that each fibre will be 
used to obtain spectroscopic information allowing only fibres directly 
opposite plaque to be activated. The major drawback with this system is 
45 
the complexity of use and the expense which may limit its clinical 
application. 
(iv) Laser Balloon 
While the rationale of most laser refinements, at least as initially 
conceived, was to avoid balloon dilatation a different approach is that 
of delivering laser energy through a balloon. With this system the ad-
vantages of balloon angioplasty are consolidated and improved. During 
the last inflation a diffusing fibre tip terminating in the balloon de-
livers Nd-YAG energy circumferentially to the artery wall. This seals 
balloon dissection planes, plaque fissures and intimal flaps and com-
presses any thermally produced vacuoles so leaving a smoother surface. 
In addition the coagulated vessel wall (peak temperatures of 100 - 140 
0 c) loses its (passive) elastic recoil or (active) spasm potential be-
coming a "biological stent" (186). After heating for 15-30 seconds the 
balloon is left inflated for a further 15-30 seconds during cooling so 
that collagen contraction does not "recoil" and narrow the lumen. Cur-
rent studies are evaluating the most effective energy delivery param-
eters for achieving satisfactory vessel wall welding (187-189). 
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1.4 SUMMARY 
Shortly after the laser was developed its properties were applied to 
the treatment of ophthalmic and dermatological conditions with consid-
erable success. Cardiovascular application was relatively late compared 
to other medical fields but was spurred on by the development of flex-
ible optical fibres that could transmit laser energies intravascularly. 
In particular its ability to vaporise atheroma was confirmed in cadaver 
and animal studies with a favourable healing response. The initial 
clinical studies, however, were disappointing due to both a high perfo-
ration rate and the ability to produce only small vascular channels 
with laser energy alone. 
A great diversity of approaches is now being employed to enhance the 
effectiveness and safety of laser angioplasty. Optimisation of energy 
dosimetry and wavelength, use of pulsed energy, enhanced plaque detec-
tion methods and modifications of the delivery systems are all undergo-
ing intense evaluation. The "ideal" laser angioplasty system has yet to 
be developed. 
At the time the studies in this thesis were performed the metal capped 
fibres had begun to show promise after the initial wave of enthusiasm 
for bare fibre angioplasty had abated. During the course of these stud-
ies alternative approaches became more attractive, and some may yet 
supersede the "hot tip" technique which in comparison may appear crude. 
Nevertheless this has been the first device to clearly establish a 
clinical role for laser angioplasty. 
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2 .1 INTRODUCTION 
The use of metal-capped optical fibres for percutaneous laser thermal 
angioplasty has achieved considerable success in peripheral artery oc-
clusions ( 173). Lesions that are impassable to the conventional guide 
wire and balloon technique are easily recanalised using the "hot tip" 
probe and importantly the incidence of perforations is very low, par-
ticularly when compared to bare fibre laser angioplasty ( 171, Section 
3. 4) . The success of this technique has led to its extension to the 
treatment of coronary artery disease, although a higher incidence of 
side effects with spasm, perforation and myocardial infarction have 
been seen (174,175,190, Section 4. 3). While the application of this 
technique to coronary artery disease also requires considerable laser 
probe design modifications, it is possible that the small coronary ves-
sels are more susceptible to thermal injury. 
The degree of vessel wall damage is proportional to the amount of en-
ergy delivered to the vessel wall and the mechanical pressure applied 
during energy delivery (102). The temperature attained by the probe de-
pends upon the rate of energy delivery and period of application, the 
mass of the probe tip, the specific heat of the probe tip materials, 
and the rate of heat dissipation into the surroundings. All these fac-
tors are either constant or controllable except the last one. Thus the 
rate of heat dissipation is the only important unknown factor in deter-
mining the probe tip temperature. Very little, however, is known about 
the temperature developed in the laser probe tip in vivo; previous 
studies have looked at the temperature developed in vitro (102,191) and 
that of the surrounding tissue (192). The development of a thermal 
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feedback control system may be useful to limit excessive injury but re-
quires detailed information on heat dissipation in different environ-
ments the and minimal effective temperatures for atheroma vaporisation. 
The aim of this study was to measure the effects of flow on the tem-
perature attained by the probe both in saline and in blood during flow 
rates observed clinically. 
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2.2 METHODS 
(a) Laser Probes 
Peripheral artery laser probes manufactured by Trimedyne Inc ( Santa 
Ana, Calif, USA) were used in this study. The "standard" 2.0 mm periph-
eral probe (PLR Plus) consisted of a 300 um optical fibre capped with a 
2. 0 mm oval metal tip. Attached to the tip was a safety wire used for 
retrieval in the event of dislodgement in vivo and a stiffening/torque 
wire for enhancing the advancement through resistant atheroma. For 
this study, the torque wire was removed and a thermocouple inserted 
into the torque wire channel. The thermocouple consisted of O. 006" 
Chromel and Alumel thermocouple wires (type "K") which were spot-welded 
to form a junction of 0.014-0.016" in diameter. The thermocouple wires 
were threaded through the torque wire channel and the junction was 
firmly wedged in place. A fine, polytetrafluoroethylene insulating 
sleeve covered one of the wires over its entire length to prevent any 
loss of the thermocouple voltage (Fig. 2 .1) . The temperature of the 
thermocouple was measured using a digital thermometer (Model 611-234; 
RS Components Ltd., UK), interfaced to a strip chart recorder 
(Servoscribe M; Servogor, Berks, UK). The 2.5 mm tip probes 
(Laserprobe-SLR) had a more rounded leading edge and was mounted on a 
600 um fibre. A type "K" thermocouple was embedded in the tip during 
manufacture to allow in vivo measurement of probe tip temperatures 
(Fig. 2. 2). Insulation was not present on the 3 mm of thermocouple wire 
adjacent to the junction which together with the optical fibre was en-
closed in a polyurethane sleeve. 
Safety wire channel Vent hole 
Thermocouple 
Torque/support wire channel 
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Safety wire Collar 
Thermocouple wires 
Figure 2 .1: Diagram of 2. 0 mm tip peripheral artery laser probe 
modified to enable tip temperature recording. 
VENT HOLES 
THERMOCOUPLE WRES 
Figure 2. 2: 2. 5 mm tip peripheral artery laser probe with a thermo-
couple incorporated in the tip. 
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(b) Laser Generator 
During this and all the subsequent studies (Sections 3,4,5) one of two 
laser generators were used: the Optilase Argon generator with power 
outputs up to 13.5 Watts and the Cardiolase 4000 Nd-YAG laser with out-
puts up to 40 Watts (both Trimedyne Inc, Santa Ana, Calif.). Prior to 
each use of either generator, the power output was calibrated using an 
appropriate sized bare fibre and a power meter. 
( c) Flow Model 
The recirculating flow rig (Fig. 2. 3) consisted of a compliant reser-
voir connected via a roller pump (R.R. flow inducer; Watson-Marlow Ltd, 
Fulmouth, England) capable of delivering up to 240 ml/minute, to a heat 
exchanger coil, leading to a straight polyethylene tube (the test seg-
ment) and returning to the reservoir. The reservoir, heat-exchanger 
coil and test section were all submerged in a water-bath maintained at 
a constant 37 °c with a heater mixer (TE-7 Tempette; Jencons Scien-
tific, Beds, UK). The laser probe was inserted through a haemostatic 
valve into the test segment and temperature was measured during energy 
delivery with varying flow rates. The test section ( 6. 0 mm diameter) 
could be renewed if damaged or replaced with fresh postmortem human 
fem oral or carotid arteries. The reservoir was able to be filled with 
saline or fresh heparinised human blood after priming the system with 
the appropriate medium. 
ROLLER PUMP 
RESERVOIR 













Figure 2. 3: Diagram of flow apparatus with test segment submerged in 
water bath maintained at a constant 37 °c. The arrows 
indicate the direction of flow. 
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( d) Measurements 
Temperature-time curves at different flow rates were recorded at paper 
speeds of 1 cm/ second and unless stated all composites are those of 
consecutive temperature-time curves from the same probe at a single 
session. The peak temperatures at the various laser powers and appli-
cation periods were obtained by recording the temperature-time curves 
at slower paper speeds and calculating the means of 3-5 consecutive 
peak measurements. All graphs derived from these calculations are com-
posed of information obtained from a single probe during a single study 
session. During the course of this study 5 modified 2. 0 mm peripheral 
artery probes and 3 purpose built 2. 5 mm peripheral artery thermocouple 
probes were used. 
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2.3 RESULTS 
(a) Saline Circulation 
In stationary saline both the 2. 0 and the 2. 5 mm probes rapidly at-
tained temperatures around 100 °c at outputs above 7 and 9 Watts re-
spectively. The peak rate of rise was greater with the 2. 0 mm probe, 
reflecting its smaller mass, with both probes reaching stable tem-
peratures within 1 and 1. 5 seconds respectively. At greater power 
outputs, the temperature was maintained at around 100 °c with more 
vigorous bubble formation (boiling), but in some probes after 3-5 sec-
onds there was a gradual rise in temperature above the plateau (Fig. 
2. 4a). The maximum temperature in these probes reached 103-109 °c. 
During maximum flow the rate of temperature rise was similar but with a 
lower more rapidly attained plateau (Fig. 2.4b). During sequential 
testing at increasing flow rates the peak (plateau) temperature fell 
with each increment in flow (Fig. 2.5). A 2.5 mm probe tested at out-
puts of 1-13 Watts over a wide range of flow rates showed a linear rise 
in temperature with increasing output up to around 85 °c at which point 
the rate of rise decreased and eventually plateaued at 100 °c (Fig. 
2.6). At temperatures of 85 °c or greater a fine cloud of bubbles ap-
peared to be dislodged from the probe tip with "true" boiling at 100 
0 c. At high flow rates the period of energy delivery had only a small 
effect on the peak temperature whereas at low flow rates it assumed a 
greater significance (Fig. 2. 7). The peak temperature was clearly 







































2.5mm PROBE at 13.0 W - No Flow 
0 5 sec 
• 3 sec 
Jt. 2 sec 
• 1 sec • 0.5 sec 
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Figure 2. 4: Temperature-time curves attained with a 2. 5 mm probe at a 
power output of 13. 0 Watts for O. 5-5. 0 second applications 


































2.0 mm PROBE at 10.0 WATTS 
3 6 
o 120 ml/min 
c.. 90 ml/min 
<> 60 ml/min 
• 30 ml/min 
• 0 ml/min 
9 
TIME (SECONDS) 
Temperature-time curves during application of 10.0 
for 5 seconds with a 2.0 mm probe at flow rates of 
ml/minute in saline. 
2.5mm LASER PROBE 
0 
100 0 0 0 i • 0 • 0 • 0 • • 0 • • • • <> • <> 80 0 • <> • • <> 6. 0 <> 6. • • <> 6. • • <> 6. • • • 6. • 0 <> 6. 60 • <> 6. • • • 6. • • <> 6. • • 0 • Q 6. • 
I ~ • 40 0 240 ml/min • 120 ml/min 
• 90 ml/min 
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Figure 2. 6: Peak temperatures recorded in a 2. 5 mm probe, after 5 sec-
onds, at flow rates of 0-240 ml/minute (saline) demon-
strate a linear rise in temperature to 85-90 °c with in-
creasing outputs, plateauing out at 100 °c. 
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a) 2.5rnrn PROBE - No Flow 
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3 6 9 12 
POWER (WATTS) 
Figure 2. 7: Peak temperatures attained by 2. 5 mm probe after applica-
tions of 0.5-5.0 seconds in a) stationary saline and b) 
saline at 240 ml/minute showing that peak temperature is 
less dependant on the duration of energy delivery at high 
flow rates. 
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(OC) 0 13 Watts 
20 0 9 Watts 
"' 5 Watts 
D 1 Watt 
I 
0 3 6 9 
TIME (SECONDS) 
Figure 2. 8: Temperature-time curves for a 2. 5 mm probe after 5 second 
applications at power outputs of 1-13 Watts in a) station-
ary saline and b) saline at 240 ml/minute. Intermediate 
output curves have been omitted for clarity 
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No two similar sized probes ( either 2. 0 or 2. 5 mm diameter tips) dis-
played identical temperature responses with greater discrepancies seen 
during high flow rates (Fig. 2.9). There were also minor variations in 
temperature responses for a particular probe between studies. While the 
results obtained during a single study session were relatively constant 
for a particular probe (standard deviations +/-1 °c for plateau meas-
urements), on some occasions repetitive testing produced "inconsistent" 
readings (both Argon and Nd-YAG energies) requiring a whole sequence to 
be repeated. The thermocouple was sensitive to the flow currents and 
when its channel was positioned closer to more turbulent flow displayed 
greater oscillations in the stable plateau temperature: simply removing 
and replacing the probe in the test segment could thus alter the tem-
perature response. In one study the temperature clearly changed sud-
denly while the power output and flow remained constant even though 
the plateau phase had been attained (Fig. 2 .10). After energy applica-
tions sufficient to raised the temperature to bubble formation, vigor-
ous agitation was needed to remove adherent bubbles, else slightly 
higher temperatures than would be expected were noted on subsequent 
testing. Boiling at the tip could occur at similar power outputs with 
recorded temperatures varying as widely as 95-107 °c on different occa-









































2.5mm PROBES - No Flow 
(13.0 WATTS) 
• Probe 1 
• Probe 2 
T --r 
3 6 9 
TIME (SECONDS) 
2.5mm PROBES - 240 ml/min 
(13.0 WATTS) 
• Probe 1 
• Probe 2 
I I 
3 6 9 
TIME (SECONDS) 
Figure 2. 9: Temperature-time curves for two 2. 5 mm probes during 13. 0 
Watt applications for 5 seconds in a) stationary saline 
and b) saline at 240 ml/minute. 
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2.5mm PROBE 12.0 W 
T 
( 120 ml/min) 










0 3 6 9 
TIME (SECONDS) 
Figure 2 .10: Temperature-time curve of a 2. 5 mm probe with constant 
flow and power output showing a sudden change in the 
"stable" plateau temperature. 
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(b) Blood Circulation 
The temperature responses in blood were highly variable at low to me-
dium flow rates. It was only at high flow rates with short duration, 
low energy applications that they became reproducible. When the 2. 5 mm 
probe was used at the highest flow rate the peak temperatures were lin-
ear over the 1-13 Watts up to a temperature of 100 °c (Fig. 2. lla). 
Once the temperature of the probe had exceeded 85-90 °c in blood, a 
variable amount of clot and char was found to be adherent to the tip 
and this increased during subsequent testing. Clot/ char on the tip pro-
duced initially successive increments in temperature (Fig. 2 .11 b) de-
spite maintained constant laser and flow parameters. After repeated en-
ergy applications the temperature became more reproducible (for each 
probe) reaching 250-550 °c (10-13 Watt applications for 5 seconds), de-
spite subsequent variations in the blood flow, usually plateauing at 
around 700 °c over a further 5-10 seconds. Initial testing in more 
slowly flowing blood rapidly heated the tip to as high as 700 °c over a 
5 second period with the 2.0 mm probe at 10 Watts (Fig. 2.12). 
After char was present on the tip, returning it into a saline circula-
tion produced completely different temperature response curves with a 
slower rise and fall though higher peak temperatures. In the example 
shown (Fig. 2.13) the temperature rise was linear up to 100 °c, 
plateauing at 120 
clot/char resulted 
0 c, yet did not boil the saline. Removal 
in temperature-time responses closer to that 
of 
ob-
tained prior to use in blood but this was not easy to do without damag-

































2.5mm PROBE in BLOOD at 240 ml/min 
• 
• • A 
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Figure 2 .11: a) Peak temperatures attained by a 2. 5 mm probe in blood 
at 240 ml/minute for applications up to 3.0 seconds. b) 
After performing the series in (a) where the tip tem-
perature in blood reached 102 °c, successive 
temperature-time curves do not describe a similar curve 
with increasingly rapid rises-. - Note that the peak tem-
peratures for applications of 0.5-3.0 seconds are now 






















Figure 2.12: Temperature-time curve of a 2.0 mm tip probe after 10 
Watts for 5 seconds - first in saline and then in blood. 
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a} 2.5mm PROBE at 13.0 WATTS - No Flow 
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(SALINE after exposure to BLOOD) 
0 5 sec 
• 3 sec ... 2 sec 
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0 3 6 9 
TIME (SECONDS) 
Figure 2 .13: Same probe as in Figure 2 .11 re-studied in a) stationary 
and b) saline at 240 ml/minute. Despite a temperature of 
120 °c after 5 seconds in stationary saline boiling at the 
tip is absent indicating an insulating effect of the 
surrounding char material. 
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(c) Human Artery Circulation 
Temperature-time and temperature-output responses in femoral and ca-
rotid artery segments were similar to those obtained in the plastic 
tube segments either in blood or in saline. Variability and inconsist-
encies were greater, however, due to inadvertent tip - vessel wall con-
tact ( either by noting adherence between power delivery sequences or on 
incising the vessel after the study). Vessel wall contact in stationary 
saline never elevated tip temperatures above 110 °c. An attempt was 
made to quantify the vessel penetration time in blood circulations by 
simultaneously kinking the vessel segment and advancing the probe onto 
the vessel wall. Greater amounts of clot/char build-up retarded ad-
vancement of the probe and the more rounded 2. 5 mm probe tip penetrated 
the wall less easily than the 2. 0 mm tip. The time varied from 30-90 
seconds in blood depending upon the state of the probe but probe attri-




Laser assisted angioplasty as a means of overcoming some of the limita-
tions of the conventional balloon procedure has become a viable manoeu-
vre using the "hot tip" thermal probe in peripheral arteries ( 173). Its 
extension to coronary disease has been less successful (174,175) due to 
the considerable differences found between peripheral and coronary ar-
teries. The thicker walled wider diameter peripheral vessels appear 
to be less prone to spasm and more resistant to the deleterious effects 
of heat. In order to develop a successful thermal control approach it 
is essential to appreciate both the probe temperature achieved in dif-
ferent environments (i.e. flowing blood, clot, atheroma, wall) as well 
as the probe temperatures required to penetrate differing compositions 
of atheroma (fatty, fibrous, calcified) while in those environments. 
In vitro studies of the "hot tip" probe applied to human aorta in air 
show that tip temperatures in excess of 180 °c are required for abla-
tion. Tissues temperatures at the same time are usually less than half 
the probe tip temperature (102). In a study of probe tip temperature 
during recanalisation of occluded peripheral arteries in vitro the t&r.1-
perature attained ranged from 130 +/- 20 °c for fatty plaque obstruc-
tion to 280 +/- 72 °c for calcified obstructions. In some calcified 
obstructions temperatures greater than 400 °c were unable to recanalise 
the vessel (193). In another study where the probe tip temperature was 
held constant, by continuously varying the output with thermocouple 
feedback control, the depth of ablation (in vivo canine femoral arter-
ies) was reported to be directly proportional to the tip temperature 
over a range of 50-400 °c (194). 
69 
This study is the first to look at the probe tip temperature developed 
over a wide range of laser powers, application periods and flow rates. 
In saline the results were relatively reproducible and the probe tip 
usually reached a steady temperature at around 100 °c in stationary sa-
line and up to 110 °c where there was vessel contact. At high flow 
rates the peak temperatures attained were considerably lower and less 
dependant on either the laser power or the time over which it was ap-
plied. Thus in vivo perfusion with saline would considerably reduce the 
probe temperature and any "lateral" heating effects of vessel not in 
direct contact with the tip (Section 4.4). 
In attempting to analyse temperature changes that might be useful for a 
feedback algorithm several inconsistencies were apparent. The rate of 
temperature development and peak temperatures varied between probes, 
particularly at high flow rates. Variable optical fibre to metal cap 
coupling during manufacture or positioning of the thermocouple within 
the tip may account for this. Thus even if algorithms can be developed 
for maximising the ablation : perforation margin it would be important 
to adjust this by testing each probe in saline at known flow rates. 
Variability in the same probe is difficult to explain but may be due to 
intermittent vent hole obstruction, inaecuracies in temperature meas-
urement, probe tip insulation effects or generator output instability. 
The vent hole normally functions to allow the escape of any gases or 
fluid between the end of the fibre and the surrounding metal cap as 
excessive expansion could force the metal cap off the fibre. This also 
allows some loss of heat: hence intermittent obstruction to the vent 
hole channel by microdebris (in the circulating medium) between energy 
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delivery sequences could affect the recorded temperatures. This phenom-
enon is likely to be accentuated in the 2. 0 mm probe with its single 
small vent hole (and in blood). The temperature measured will depend on 
the exact position of the thermocouple within the probe tip as there is 
a small delay in temperature spread across the probe (102), effective 
thermal contact, and the success of insulating the thermocouple wires 
from the junction inside the tip to the temperature meter. 
Micro-displacement of the junction or its insulation during use (as in 
negotiating the haemostatic valve) might be important. In addition the 
temperature in the thermocouple channel is highly sensitive to oscilla-
tions in flow: exposure to the mainstream flow or eddy currents and 
partial or intermittent obstruction of its channel by debris or bubbles 
could also affect the recorded temperatures. Tip insulation by small 
vapour bubbles (air coming out of solution at +/- 85 °c or boiling near 
100 °c) resulted in slightly higher tip temperatures if these bubbles 
were not meticulously removed from the probe tip surface. This probably 
accounts for the late rise in "plateau" temperatures seen in some stud-
ies. Small variations in the generator output become important at low 
flow rates. In the single instance where a stable plateau temperature 
suddenly changed this may have been due to a change in the generator 
output or dislodgement of a bubble from the thermocouple channel. 
In blood the probe tip temperatures attained were variable reaching up 
to 700 °c in stationary blood within 5 seconds. When heated in a blood 
medium the laser probe coagulated blood surrounding it with the forma-
tion of a thin layer of char and thrombus which became more extensive 
over time (191). This tended to slow the rate of rise ( and fall) in 
temperature and while the peak temperatures were higher the clot/char 
71 
prevented dissipation of heat to the surroundings. Using aluminium 
capped fibres (temperatures in air are only 50% of the Trimedyne probes 
used here) Silverman et al found that adventitial temperatures in vitro 
were similar when lasing in blood or saline despite the higher probe 
temperature in blood ( 195). In vivo the blood medium might initially 
raise tip temperatures and enhance ablation until the development of a 
coagulum insulates it and then retards further ablation. After a number 
of energy delivery sequences the temperature profile is likely to be-
come reproducible with the development of a larger clot. In clinical 
practice the probe is constantly agitated to try prevent char build up: 
the degree of tissue contact and any "abrading" effect on the char 
while negotiating an obstruction are additional complicating factors in 
interpreting the temperature response. 
Conclusions: It is unlikely that probe tip temperature monitoring or 
stabilisation via a thermal feedback control circuit will be able to 
limit thermal damage in blood. Probe tip temperature is critically de-
pendant upon the rate and amount of char and clot build-up and the rate 
of blood flow at any given time. Char build up will depend on the blood 
flow at the time of energy delivery while blood flow in relationship to 
the probe will vary during the recanalisation process itself. A con-
trolled saline flush at the time of laser thermal angioplasty may allow 
a constant temperature to be developed due to the heat sink effect of 
saline and the absence of char/ coagulum build-up. This may only be 
effective however in stenotic disease and not while the probe is tra-
versing a long occlusion. Finally, elimination of the variability in 
temperature responses of the probes themselves would be necessary for 
such an approach. 
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3.0 PERIPHERAL ARTERY LASER THERMAL PROBE ASSISTED ANGIOPLASTY 
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3. 4 DISCUSSION 
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3 .1 INTRODUCTION 
Percutaneous translurninal angioplasty in peripheral artery disease is a 
well established procedure with high technical success rates in 
stenotic disease ( 196). The success rate in occlusions is not as high 
mainly due to difficulties in negotiating the lesion with a guide wire, 
and this is more common with older and longer lesions. The guide wire 
tip may dissect the wall of the artery and even perforate it with suc-
cessive attempts often re-entering the false channel. The long term 
success rate of dilatation is highly dependant on an adequate distal 
"run off" but in addition the length of the occlusion is also inversely 
proportional to the long term outcome ( 197-201). 
Early attempts at laser recanalisation using conventional optical fi-
bres were often technically successful but balloon dilatation was al-
ways necessary. In some of these patients laser energy was only deliv-
ered during retrograde withdrawal after the fibre had successfully 
negotiated the lesion or was used for subtotal occlusions. Thus the 
clinical benefit from the procedure appeared to be marginal 
(66,67,138). The initial study of the laser thermal probe by Cumberland 
et al was encouraging, with a high recanalisation rate (albeit still 
requiring balloon dilation) and low perforation rate, and included many 
patients with prior unsuccessful balloon angioplasty procedures ( 173). 
This study assessed the abilities of the laser thermal probe to cross 
peripheral artery occlusions. In addition the effectiveness of laser 





Patients were referred from Guy's hospital and its peripheral catchment 
hospitals by physicians, surgeons and radiologists. In 8 of the 9 pa-
tients treated, previous angioplasty procedures had failed or were con-
sidered to be impossible or very difficult using conventional tech-
niques. In one patient the laser was used in two relatively short 
occlusions with the aim of simultaneously "debulking" rather extensive 
adjacent non-occlusive disease. Informed consent was obtained from each 
patient who otherwise received standard pre and post angioplasty care. 
Heparin 20,000 units was infused over 24 hours in successful cases but 
antiplatelet therapy was not used routinely. Ankle-brachia! indices 
were measured before and after the procedure with a sphygmomanometer 
and/or Doppler. 
(b) Laser Probes 
The "hot tip" laser probes (Fig. 3.1) consisted of an olive shaped 
metal cap 4 mm long and 2 mm in diameter which was firmly fixed onto a 
300 um core optical fibre by a 6 mm metal collar. A 3. 5 cm safety wire 
was attached to the metal cap and crimped onto the fibre proximally to 
enable retrieval in the event that the metal cap detached itself (by 
attaining sufficiently high temperatures to melt the optical fibre). In 
addition a 175 cm support wire was attached to the tip to enhance the 
coaxial force that could be applied to the lesion. The probe itself was 
rather inflexible due to the terminal 1 cm long metal components (tip 
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plus collar) as well as the rather stiff 300 um fibre. The ability to 
steer the probe was thus rather limited: collar angulation (ex vivo) 
with rotation of the probe was the only manoeuvre available apart from 
advancement. 
Figure 3 .1: A 2. 0 mm tip laser probe with its 300 um core fibre. A 
safety wire (upper) and support wire (lower) are attached 
to the tip. Alongside is the corresponding 300 um core 
bare optical fibre with its jacket partially removed at 
the tip ( see also Figure 1.1) . 
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(c) Procedure 
The procedures were performed in the cardiac catheterisation laboratory 
where the laser generator was installed using fluoroscopy with video 
playback and cine-angiography. Prior to each treatment the argon laser 
generator was set at 10 Watts and output was checked using a bare fibre 
and a power meter. The laser probe was introduced through an SF haemo-
static sheath placed in the ipsilateral femoral artery in all but one 
patient (brachial approach). Advancement using fluoroscopy was guided 
by marking skeletal and other land marks ( such as the limits of the oc-
clusion and origins of collaterals) on the video screen. During energy 
delivery a continuous to and fro motion was used which was maintained 
for 3 - 5 seconds after power was switched off to avoid the probe ad-
hering to the vessel wall. Contrast was used frequently to monitor 
progress through these lesions none of which had been crossed by a 
guide wire. On crossing the occlusion free movement of the probe in 
the distal vessel and contrast administration confirmed its 
intraluminal position. Balloon dilation then proceeded using guide 
wires and balloons of appropriate dimensions. After the procedure the 
cine-angiograms were projected onto a screen and vessel and lesion di-
ameters measured before and after each intervention with callipers 
(referenced to the 2. 0 mm diameter tip) . 
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3.3 RESULTS 
The probe successfully recanalised 8 of the 10 occlusions (length 1-12 
cm) after 1 to 10 energy applications (total energies of 70-1100 
Joules). During energy delivery three patients had some discomfort 
which was mild in two and moderate in one - similar in intensity to 
contrast administration. Advancement of the probe was relatively rapid 
and resistance to progression was infrequent. Even when the probe per-
forated the vessel wall in two cases the tactile sensation was no dif-
ferent to that of intravascular progression and the perforation was 
only apparent after deviation of the probe from the expected course or 
after contrast administration. In three patients after crossing the oc-
clusion with the laser probe the guide wire was unable to follow lead-
ing to a further two unsuccessful cases wit:ri perforations in both. In 
the third patient the guide wire was replaced with the laserprobe which 
was then easily re-advanced across the lesion without further energy 
delivery. The fibre itself was cut proximally and used as a guide wire 
for balloon placement. Subintimal dissection with re-entrance into the 
lumen and subsequent successful balloon dilatation was evident in two 
patients. While the first instance was readily apparent during the pro-
cedure in the second it was only evident on review of the developed 
cine-angiograms. 
In the six occlusions (five patients) successfully recanalised by the 
laser and subsequently dilated with the balloon the long term outcome 
was mixed. In a patient with Buergers disease and rest ischaemia no 
improvement occurred despite improved large vessel flow. In a second 
patient with rest pain and poor distal run off (double occlusion) only 
78 
modest improvement occurred due to early occlusion of the distal le-
sion. In three patients very good short term results were present but 
one relapsed two weeks later with a presumed re-occlusion. In the two 
remaining patients complete symptomatic relief was maintained over a 
year later (Fig. 3. 2). 
Clinical characteristics of the patients and the procedural techni-
calities are summarised in Table I and described further in the follow-
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Figure 3. 2: Out come of laser thermal probe assisted angioplasty in 
10 peripheral artery occlusions ( 9 patients). 
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*** = use of "cold" laser probe to negotiate the 
lesion prior to balloon dilatation. 







































Patient 1 ( FM) 
A 77 year old man had claudication in the right calf after walking 200 
yards on the flat forcing him to rest for five to ten minutes after a 
further 400 yards. His symptoms had been present for 18 months and 10 
months previously angiography had revealed an 8 cm total occlusion of 
the right popliteal artery (Fig. 3. 3 [ 1]). Conventional angioplasty was 
unsuccessful and he was subsequently referred for a laser procedure. 
Angioplasty Procedure: The 2 mm laser probe was advanced via an SF 
sheath in the right femoral artery to the proximal end of the occlu-
sion. Energy at 10 Watts was delivered with applications of 13, 8, 9 
and 4 seconds whilst the occlusion was crossed and a further 16 second 
application during withdrawal across the entire length of the lesion. 
Angiography revealed an irregular tract with a minimum diameter of 1. 6 
mm and a maximum of 3. 5 mm (Fig. 3. 3 [ 2] ) . During su bseq uen t passage 
of the tract with a conventional J guide wire and balloon dilatation 
catheter the guide wire perforated close to the end of the occlusion 
(Fig. 3. 3 [ 3]) . Thereafter it proved impossible to recross the lesion 
and the procedure was abandoned. 
Post Angioplasty Course: The patient developed a large haematoma in the 
popliteal fossa which did not impede mobility or perfusion via his 
original collaterals and he was discharged 48 hours later. The 
haematoma resolved over the succeeding 4 weeks and his physical limita-
tions were unchanged. He declined any further interventional procedures 
or surgery. 
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Figure 3. 3: The 8 cm occlusion in the right popliteal artery [ 1] is 
easily crossed by the laser probe and produces a 1. 6-3. 5 
mm channel [ 2] . During passage of the guide wire a perfo-
ration occurs and it is thereafter impossible to recross 
the lesion. There is extensive dye extravisation [ 3] with 
} 
the development of a large popliteal haematoma. 
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Patient 2 (AM) 
This 60 year old man had a traumatic right below knee amputation as a 
young man and suffered from severe chronic obstructive airways disease 
requiring domiciliary nebulizers and oral steroid therapy. He was ad-
mitted with rest pain due to ulceration over the 1st and 5th digits of 
his left foot of 6 weeks duration. Foot pulses were absent below the 
left femoral pulse and the ankle/ brachial index was 0.42. 
Arteriography revealed short occlusions of the distal superficial 
femoral artery (1 cm) and of the popliteal artery (2.5 cm) with exten-
sive non-occlusive disease and poor distal run off. 
Angioplasty Procedure: The 2 mm probe easily crossed both occlusions 
requiring 8 seconds at 10 watts for passage through the proximal lesion 
while six applications were delivered to the distal lesion - 3, 6, 8 
and 6 seconds during forward passage and 6 and 9 seconds during with-
drawal. At this time the luminal diameter appeared to be a maximum of 
2 mm at both sites. A 4 mm balloon was then inflated in the proximal 
lesion resulting in a lumen of 3-4 mm throughout its length. At this 
point the second lesion had re-occluded, though it was easily crossed 
with a guide wire alone and dilated to a diameter of 3 mm with the 4 mm 
balloon. 
Post Angioplasty Course: Three days later his foot felt warmer 
less pain and the ankle/brachial index had improved to 0.66. The 




re-occluded with maintained patency at the proximal femoral artery le-
sion. The improvement was only short lived and three months after the 
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procedure he continued to experience rest pain and his ulcers had not 
healed. Nine months later balloon dilatation was performed for a right 
iliac stenosis together with a chemical sympathectomy and there was 
gradual healing of his foot ulcers. 
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Patient 3 (LC) 
This 75 year old man had worsening claudication in his left calf over a 
six month period and was only able to walk for 25 yards on the flat. 
In the weeks prior to his admission he had begun to suffer with rest 
pain at night. There were no foot pulses below the left femoral pulse 
and angiography revealed a 7. 5 cm occlusion of the distal superficial 
femoral and popliteal artery with run off to a patent posterior tibial 
vessel only (Fig. 3.4 [1]). Conventional angioplasty was attempted at 
a peripheral hospital without success. 
Angioplasty Procedure: The 2.0 mm laser probe easily crossed the lesion 
with two applications of 10 and 7 seconds and the channel was further 
enlarged with additional 20 and 21 second withdrawal and 
re-advancements (Fig. 3.4 [2]). The resultant channel measured 0.5-1.6 
mm in diameter (Fig 3.4 [3]) but the J guide wire was unable to negoti-
ate the whole lesion and perforated the vessel wall at a distance of 4 
cm (Fig. 3. 4 [ 4]) . Thereafter it was impossible to pass either a vari-
ety of floppy tipped guide wires or the laser probe itself without en-
tering the false tract and the procedure was abandoned. 
Post Angioplasty Course: There were no symptoms or signs of the perfo-
ration and four months later he underwent femoro-popliteal bypass 
grafting. Postoperatively he had a myocardial infarction and a further 
fatal myocardial infarction three weeks later. Postmortem examination 
was not performed. 
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Figure 3. 4: The distal superficial femoral occlusion [ 1] is easily 
crossed by the laser probe (white arrow) in [2]. A narrow 
tract (black arrows) is apparent [3] but the guide wire 
perforates (open black arrow) with dye extravisation [ 4]. 
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Patient 4 (SB) 
A 37 year old man with Buergers disease, who continued to smoke, under-
went sequential amputations culminating in bilateral below knee amputa-
tions. He presented with rest pain and a swollen tender ischaemic 
stump on the right with a barely palpable femoral and absent popliteal 
pulse. Angiography revealed a 5 cm occlusion of the common femoral ar-
tery which did not allow direct percutaneous access for angioplasty 
(Fig. 3 . 5 [ 1 ]) . 
Angioplasty Procedure: The laser probe was introduced via a 9F long 
sheath (internal diameter of 2. 3 mm; Angiomedics, France) inserted 
through a left brachial arteriotomy and advanced to the common femoral 
stump (Fig. 3.5 [2-3]). The lesion was crossed with two applications 
of energy at 7 and 8 seconds and was further dilated with two applica-
tions during withdrawal for 9 and 10 seconds (Fig. 3. 5 [ 4]). During the 
last two energy deliveries it became noticeably more difficult to con-
tinuously agitate the probe. Contrast administration revealed that the 
original occlusion had consisted of a proximal and distal occlusion 
with a much larger lumen between these two points after laser energy 
delivery (Fig. 3. 5 [ 5]). On attempting to withdraw the probe back into 
the sheath resistance was encountered although the probe was still able 
to be advanced quite freely through the lesion itself. An exchange 
guide wire was then passed down the sheath alongside the laser probe 
and across the lesion allowing the sheath and probe to be removed as a 
single unit. Difficulty was again encountered on final withdrawal 
through the brachial arteriotomy and this was found to be due to a 
build up of char on the probe tip (Fig. 3.6). Dilatation with a 6 mm 
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Figure 3. 5: The common fem oral artery has a 5 cm occlusion with some 
calcified lesions (white arrow) [1-2]. The guiding sheath 
is advanced to the stump [ 2] and the laser probe ( open 
white arrow) is advanced through the lesion [3-4]. After 
initial passage of the probe it is apparent that the 
occlusion consisted of shorter proximal and distal occlu-
sions (black arrows) with an intervening relatively normal 
segment [ 5] . After balloon dilatation the lumen is much 
improved (half strength contrast injection) [6]. 
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balloon resulted in a 4. 5-4. 7 mm vessel (Fig. 3. 5 [ 6]). 
Post Angioplasty Course: Despite the technically successful angioplasty 
procedure his symptoms were not improved and an above knee amputation 
was performed 3 days later. This stump remained ischaemic and required 
a revision 2 months later. Eight months later he was admitted with 
mesenteric ischaemia and two months after that with digital ischaemia. 
Figure 3. 6: A large spur of char is adherent to the probe tip 
which prevents its withdrawal into the guide sheath. 
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Patient 5 ( FB) 
A 64 year old man had a seven year history of left calf claudication at 
a distance of 200 yards. Pulses were absent on the left and the ankle-
brachial index was O. 71 . Angiography revealed a 2 cm occlusion of the 
left common illiac artery but angioplasty was unsuccessful (Fig. 3. 7 
[1]) 
Angioplasty Procedure: The contralateral femoral artery was first 
cannulated and a pigtail catheter placed proximal to the lesion in the 
aorta. Contrast administration enhanced successful puncture of the 
ipsilateral impalpable femoral artery and the 2 mm laser probe was ad-
vanced to the lesion (Fig. 3. 7 [ 2]) . After a single application of la-
ser energy for 7 seconds the probe had virtually crossed the length of 
the occlusion but was seen to be in a plane parallel to the anticipated 
lumen (Fig. 3. 7 [ 3]). Further energy was not delivered but gentle 
pressure was able to advance the probe into the aorta (Fig. 3. 7 [ 4]). 
Angiography confirmed a 1-1. 5 mm channel medial to the anticipated 
lumen (Fig. 3. 7 [5]). After passing a deflated 10 mm balloon through 
this tract it assumed a position closer to that of the anticipated 
lumen. A single inflation was then able to restore the vessel to its 
normal calibre (Fig. 3. 7 [ 6] ) . 
Post Angioplasty Course: The peripheral pulses were palpable immedi-
ately after the procedure and the ankle/ brachial index rose to O. 97. 
The patient had a dramatic improvement in his exercise tolerance which 
persisted over a year later. Review of the films confirmed that the la-
ser probe had passed through a tract adjacent to that of the expected 
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lumen but there was no evidence of a dissection or extravasation on the 
final injection. 
Figure 3. 7: The 2 cm iliac occlusion [ 1] is approached retrogradely 
from the femoral artery and the laser probe (tip arrowed) 
is advanced with slight buckling [2]. The probe tip is 
seen to lie inf eromedial to the proximal stump [ 3] , as is 
the support wire after advancing the probe into the aorta 
[ 4] . After withdrawal of the probe to the distal vessel a 
tract ( small arrows) is clearly seen [ 5] but after balloon 
dilatation recanalisation is complete [ 6] . 
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Patient 6 (LB) 
A 76 year old woman presented with a two year history of right calf 
claudication at a distance of 200 yards. The foot pulses were only 
weakly palpable with an ankle/brachial index of 0.54. A 6 cm occlusion 
of the distal superficial femoral artery was found with numerous 
collaterals draining into a large siphon at the distal end of the oc-
clusion in the popliteal fossa (Fig. 3. 8 [ 1]). A discrete posterior 
tibial stenosis was also present. After an attempt at conventional 
angioplasty had failed at a peripheral hospital she was ref erred for 
laser probe angioplasty. 
Angioplasty Procedure: The 2 mm laser probe easily crossed the occlu-
sion after 8 seconds (Fig. 3 . 8 [ 2] ) and the channel was further en -
larged with a 9 second application during probe withdrawal. The channel 
produced was less than 1 mm in diameter at its narrowest point (Fig. 
3. 8 [ 3]) but after dilatation with a 6 mm balloon a normal calibre 
channel was obtained (Fig. 3.8 [4]). This enabled dilatation of the 
posterior tibial vessel with a 4 mm balloon at the same session. 
Post Angioplasty Course: Review of the developed cine-films revealed a 
double lumen involving the drainage popliteal siphon distal to the end 
of the occlusion which had occurred at the time of the laser probe ad-
vancement (Fig. 3. 8 [ 2-4]). Doppler studies showed that the 
ankle/brachial index had increased to 1. 03 and she remained symptom 
free over a year later. 
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Figure 3. 8: The 6 cm distal femoral occlusion [ 1] has been crossed by 
the laser probe [ 2] and its position is marked by the 
radio-opaque support wire (small arrows) with a double 
lumen present in the popliteal artery (large arrows). In 
panel 3 the probe has been withdrawn and the empty arrows 
show the residual tract. After balloon dilatation is com-
pleted a residual double lumen is still present [ 4]. 
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Patient 7 (WR) 
This 62 year old insulin dependant diabetic man had suffered with clau-
dication in both calves for eighteen months. Pain was worse in the left 
calf and he continued to smoke 10 cigarettes a day. There was diffuse 
disease throughout the right superficial femoral artery and popliteal 
on the right and a 12 cm long occlusion of the left superficial femoral 
artery (Fig. 3.9 [1]). 
Angioplasty Procedure: The 2. 0 mm probe was advanced relatively easily 
through the occlusion using three energy applications at 11, 10 and 9 
seconds (Fig. 3. 9 [ 2] ) . At 2-3 cm proximal to the end of the occlusion, 
however it appeared to enter a side branch (Fig. 3.9 [3]) and then de-
viated away from the popliteal artery with a false tract formation 
(Fig. 3. 9 [ 4]). Further attempts using the laser probe (without energy 
delivery) and guide wires resulted in persistent entrance into the 
false tract. 
Post Angioplasty Course: Despite the perforation he did not develop a 
haematoma and his symptoms were unchanged after the procedure. He 
elected to discontinue smoking and to consider a repeat procedure some 
months later if his symptoms persisted. 
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Figure 3. 9: The proximal and distal ends of the distal superficial ar-
tery occlusion are marked by the open and closed black ar-
row respectively and the origin of a collateral network by 
the white arrow [ 1]. The laser probe advances within the 
lumen until the point where the collaterals originate 
[ 2-3] and then deviates with a resultant perforation and 
small amount of dye extravisation (small white arrows) 
[ 4]. 
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Patient 8 (AT) 
This 52 year old man had developed left calf claudication after an aor-
tic valve replacement for infective endocarditis five years previously. 
Angiography previously had revealed occlusion of the distal popliteal 
artery with the trifurcation vessels filling via collaterals (Fig. 3 .10 
[ 1]). Conventional angioplasty was not attempted because it was thought 
to be unlikely to succeed and he was then ref erred for laser assisted 
angioplasty. 
Angioplasty Procedure: When the 2 mm probe was advanced into the stump 
of the popliteal artery it appeared to be pointing towards the 
peroneal artery (Fig. 3.10 [2]) but on advancement during laser energy 
delivery it immediately diverted towards the anterior tibial artery 
(Fig. 3 .10 [ 3]). Four applications of energy at 5, 7, 3, and 6 seconds 
were delivered and it appeared that the probe was on course for the an-
terior tibial artery. The probe then deviated medially and a false 
tract was created (Fig. 3.10 [4]). 
Post Angioplasty Course: The patient did not develop a haematoma and 
cir cu la tion to his foot was unchanged. 
follow-up. 
He was subsequently lost to 
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Figure 3 .10: There is an occlusion of the popliteal artery with 
collateralisation of the trifurcation vessels [ 1] . The 
laser probe (open white arrow) appears to be heading to-
wards the peroneal artery [ 2] but deviates towards 
the anterior tibial artery [ 3] . Just proximal to the end 
of the occlusion it perforates the vessel ( solid white ar-
row) causing a small amount of dye extravisation (small 
white arrows) [ 4]. 
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Patient 9 ( EW) 
This 7 4 year old man presented six years after coronary artery bypass 
grafting with claudication in the left calf at a distance of 200 yards. 
His symptoms had been worsening over the preceding three years and at 
the time of admission he had begun to experience nocturnal cramp. 
There were no pulses present below the femorals and angiography re-
vealed an 8 cm occlusion of the left superficial femoral artery with 
diffuse disease in the right superficial femoral artery (Fig. 3 .11 
[ 1]) . An angioplasty procedure to the occluded left superficial femoral 
artery failed at a peripheral hospital and he was referred for laser 
angioplasty. 
Angioplasty Procedure: The 2 mm probe was easily advanced across the 
total length of the occlusion using 11 applications of energy ranging 
between 9 to 11 seconds and advancing only 2-3 cm with each application 
(Fig. 3.11 [2-3]). Despite delivery of a total of 1100 Joules energy 
the channel produced was only 1-2 mm in diameter and it was impossible 
to cross with a J guide wire. The laser probe was then easily 
re-advanced through the lesion without energy delivery and the laser 
fibre cut and used as the "guide wire" for a 6 mm balloon. After 6 in-
flations the lumen was increased to a diameter of only 3. 7-5. 2 mm (Fig. 
3 .11 [ 4]). Review of the cine-angiograms revealed a mobile mural 
thrombus in the popliteal artery but this was no longer present after 
passage of the laser probe (Fig. 3 .11 [ 1-4]). Its presumed dislodgement 
was clinically innocuous and in all probability its presence would not 
have been detected if cine-angiography had not been used. 
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Post Angioplasty Course: The ankle brachia! index increased from O. 56 -
0. 69 and the patient experienced marked symptomatic improvement. Two 
weeks later he noticed a recurrence of calf pain while walking with 
limitations similar to before the procedure but declined further inves-
tigations. 
Figure 3 .11 The 8 cm occlusion [ 1] is easily crossed by the laser 
probe (black arrow) and dilatation proceeds uneventfully 
[4]. A small mobile thrombus (small black arrows [2-3]) 
is present in the popliteal artery but this is no longer 
apparent after passage of the laser probe and balloon 
dilatation. 
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3. 4 DISCUSSION: 
Various manoeuvres are used to cross peripheral arterial occlusions but 
all run the risk of subintimal dissection or even perforation. The risk 
increases proportionately to the amount of force used and success de-
creases with increasing occlusion length (197-201). The onset of 
subintimal dissection often heralds failure as subsequent attempts to 
cross the lesion using different guide wire and catheter combinations 
invariably follow the false tract. Advancement down the subintimal 
channel is difficult with a guide wire alone while stiffer catheters 
are more prone to perforation. 
Laser energy was first used clinically in order to overcome some of the 
limitations of the conventional guide wire and balloon procedure in 
long occlusions in the femoro-popliteal segment (66,67 ,138). Laser 
angioplasty using bare optical fibres however was accompanied by a high 
perforation rate due to mechanical penetration of the wall with the 
stiff bare fibre or due to energy delivery with the fibre in an eccen-
tric position. While these perforations were innocuous even successful 
procedures only produced small increments in luminal diameter which 
were not thought to be clinically beneficial ( 66, 67,138). In a number 
of these lesions laser energy was only delivered in a retrograde fash-
ion once the occlusion had been crossed and as balloon dilatation was 
always a necessary accompaniment to the procedure its advantage was 
minimal (66,67). The laser thermal probe presents a smooth oval shaped 
tip to the occlusion allowing the use of relatively large amounts of 
force with a low risk of mechanical perforation (168,171). It has even 
been used as an "atraumatic" guide wire without energy delivery though 
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with only limited success (202). During energy delivery the tip is rap-
idly heated and steadily ablates obstructive atheroma as it is advanced 
and produces larger channels than bare fibres (171). Nevertheless bal-
loon dilatation is still necessary and is able to produce much greater 
improvements in luminal calibre than the laser probe alone. Patient 5 
where the 1 mm channel was increased to 9 - 11 mm is a good example 
while in patient 2 the small channel produced had already closed off 
in the time taken to dilate the proximal lesion. Build-up of char on 
the probe may be substantial in long segment occlusions and may "insu-
late" the probe so preventing further efficient ablation of atheroma 
( Chapter 2. 3). This was particularly evident in patient 4 where the 
spur of char hindered further manipulation and made the tip too large 
to withdraw into the sheath. In patient 9 where the greatest amount of 
energy was delivered the channel was no better than in the other pa-
tients indicating that tip insulation and/or composition of the occlu-
sion are critical at determining the amount of atheroma ablation and 
thus the residual tract size. 
There is evidence from in vitro application of thermal energy to aor-
tic strips to suggest that the normal vessel wall is less vulnerable to 
heat than atheroma though these studies were performed in air with low 
powers ( 102). Clinical perforations are infrequent ( 173,203, 204-209) 
and thought to occur when a particularly resistant (often heavily cal-
cified) lesion deflects the advancing probe against and through the op-
posite normal vessel wall (210,211). During its blind negotiation of 
the occlusion, entrance into side branches or collaterals may also mis-
direct the probe tip resulting in failure. The latter appears to be 
the reason for the perforation in one of these patients; in the other 
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the probe "deviated" off course for no obvious reason but presumably 
followed the line of least resistance. Peripheral artery perforation 
is usually uneventful as it usually occurs towards the end of a long 
occlusion segment so that in the absence of balloon dilatation flow is 
low. Resistance from the lesion itself however is indistinguishable 
from that of the vessel wall and was no different in either the perfo-
rations or subintimal dissections described here. It is interesting 
that after laser thermal energy delivery it was possible to perforate 
the vessel with the guide wire alone in two of these cases. It is un-
clear whether the channel left after the laser recanalisation is more 
prone to perforation because of the irregular surface or heat weakened 
segments or both. In the last patient of this series the guide wire 
would not traverse the channel, but the smooth oval metal probe did so 
easily and was used as a guide wire for the balloon thereafter, sug-
gesting the former mechanism is at least in part responsible. 
Subintimal dissection has been recorded previously using the laser 
probe ( 173,203) but it was unclear whether as in two of these patients 
dilatation was still possible through the subintimal tract. It is 
likely that the probe progressed through atherosclerotic plaque after 
deviation away from the central "soft" intimal atheroma but that in the 
absence of sufficiently large contralateral calcific deposits the media 
nevertheless prevented further lateral displacement. This is almost 
certainly the explanation in the iliac occlusion where the bulk of the 
deflated balloon alone was able to reconnect the "false" and "true" 
channels. In the other case two definitive channels remained so that 
substantial intimal thickening must have been present to prevent their 
"coalescence". It is still surprising that the non-dilated original 
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lumen remained widely patent. Two other studies, one surgical (212) and 
one cadaveric ( 211) have found subintimal dissection for greater or 
lesser lengths to be very common and it seems as though this may be one 
of the mechanisms of successful dilatation. It is possible that un-
recognised subintimal dissection and even perforation are commonplace 
with both balloon angioplasty and the newer interventional techniques 
as local tamponade has been shown to mask angiographic documentation of 
perforations later found to be present on histology (162,213). 
The patients treated here had, by and large, more difficult lesions 
than the standard patient in whom angioplasty is attempted. The defini-
tion of "difficult" is necessarily subjective though recanalisation of 
lesions in which angioplasty has previously failed is probably a rea-
sonable indicator. No comparative literature exists for the outcome of 
non-surgical treatment of unsuccessful angioplasty, but even by exclud-
ing the patient with the two short occlusions this leaves a 75% techni-
cal success rate with the laser probe (6 out of 8). Cumberland's 
initial study reported a success rate of 78% in occlusions that had 
failed or were considered "impossible" or "difficult" for conventional 
angioplasty. The overall success rate including their "easy occlu-
sions" was 89% (173) which compared favourably to the 26-78% achieved 
by a number of groups in total occlusions using guide wires alone 
(197-201). 
The long term results in this series were not impressive but needed to 
take into account the "learning curve" (with two "technical successes" 
converted into failure with the guide wire) and the selection of pa-
tients. Of the five patients with technically successful results 
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( six lesions) two had poor run off ( three lesions) and were not 
clinically improved by the procedure. In the remaining three patients 
two had a good long term result. A larger series of laser thermal 
probe angioplasty by Sanborn et al shows a one year patency rate of 77% 
(203) compared to that in conventional series ranging from 56-84% of 
successful procedures ( 197-201). Other smaller series of laser thermal 
angioplasty ( 7 - 46 patients) have been reported with success rates be-
tween 48 - 90% ( 204-209, 211) and in none were perforations or dissec-
tions of any important consequences. The lowest success rate was in the 
largest series ( 209) which identified occlusions greater than 15 cm or 
below the knee as having the worst results. Conversely in the only se-
ries in which a failed conventional angioplasty procedure was a pre-
requisite for inclusion, was there a success rate of 78% in 14 patients 
(206). In one series high grade stenoses were also included (207). Of 
the patients successfully treated (all with a balloon procedure after 
the laser) 75 - 80% have remained clinically improved over follow up 
periods of 1 - 9 months. Thus, once the laser pro be has allowed balloon 
dilatation to proceed the results are at least as good as in those le-
sions in which a guide wire is able to cross by itself. It is however 
by no means clear whether the thermal debulking or ablation of atheroma 
that accompanies the procedure is in itself important for long term 
patency. There was no correlation between the amount of energy deliv-
ered during recanalisation and the lumen diameter either before or af-
ter balloon dilatation in this or any of the other studies. 
The laser probes used in this small series have undergone further de-
velopments aimed at improving the lumen and avoiding the need for bal-
loon dilatation. The original "hybrid" probe studied by Abela 
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intra-operatively (101) has been used for percutaneous angioplasty and 
larger luminal calibres have been claimed (214). It has been postulated 
that the "free" laser beam (now more commonly of the deeper penetrating 
Nd-YAG wavelength) component "softens" the atheroma allowing easier 
passage with less lateral deviation and more efficient ablation (214). 
The probes have all been 2. 5 mm or greater with more rounded tips and 
this alone could account for the larger luminal diameters than were 
achieved previously by the 2. 0 mm "hot tip" probes. Furthermore once 
the initial channel has been produced larger probes may then be 
over a guide wire to further enlarge the lumen. The hybrid and 




time of vascular surgery with or without concomitant endarterectomy, 
balloon dilatation and bypass grafting. Dietrich reported on over 1000 
lesions so treated with over 80% success though many had short stenotic 
lesions only or had not undergone balloon angioplasty attempts 
(212,215). This large though heterogeneous series does therefore not 
add evidence to suggest the laser probe approach is superior to conven-
tional percutaneous angioplasty or even bypass surgery. Indeed a study 
of peripheral angioplasty in a community hospital with access to a 
thermal probe found that 84% of 120 procedures in a 7 month period were 
successful with the guide wire and balloon alone. In 6 cases in which 
the conventional procedure failed the thermal probe was successful in 
4. They felt that the laser had not significantly increased the number 
of patients amenable to angioplasty and that it was not cost effective 
for a small hospital (216) as has been noted by others (202). 
Laser energy heating of the metal tip is also no longer the only avail-
able heat source. Radiofrequency heating of metal tips has been shown 
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to be as effective at crossing total occlusions despite a lower working 
temperature (500 °c in air). Major advantages are the lower costs and 
mobility of the radiofrequency generator ( 217,218). Long term results 
are still awaited but it is likely that these will be similar to those 
seen after laser "hot tip" procedures. It is unclear whether these de-
vices could produce the "larger" channels seen with the increased diam-
eter and hybrid probes. 
The contact sapphire tipped fibres have also established themselves in 
this setting. One series comparing the sapphire tipped fibres to the 
thermal probes found they produced larger channels with a slightly 
higher success rate ( 78% versus 82%) but this was not a randomised 
study (14 thermal probe; 74 sapphire tip) (206). Other studies with 
8-33 patients have shown similar recanalisation rates with this system 
(178-180, 219-221). In a small proportion of patients balloon 
angioplasty has not followed when the lumen was felt to be adequate 
with the laser alone - at least 50% of the original lumen ( 219) though 
in another study vessels so treated occluded soon after the procedure 
(221). 
Argon energies delivered via lensed fibres have also been successful at 
recanalising total occlusions (88% of 26 attempted) without any adverse 
effects. The lensed fibre is passed through a "centering balloon" which 
maintains coaxial alignment but the lumen obtained is inadequate unless 
followed by subsequent balloon dilatation (222). 
The first successful clinical application of a "smart" laser with 
fluoroscopic monitoring has recently been reported ( 223). A low power 
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helium-cadmium laser emitting 325 nm light is used to induce 
intravascular fluorescence with on-line spectroscopic analysis. Only if 
the analysis confirmed the signals are from atheroma was laser energy 
at 480 nm from a tunable dye laser delivered through the same optical 
fibre. In 19 patients recanalisation was possible in lesions that were 
impassable to a guide wire though in 1 the channel was too small to al-
low the balloon catheter to complete the recanalisation. The first 
pulsed excimer systems have also been used successfully, though need to 
have a guide wire across the lesion before energy delivery and also re-
quire balloon dilatation to complete the procedure (224,225). 
A number of new interventional techniques have also been applied to the 
treatment of occlusive peripheral vascular disease. These include 
various atherectomy catheters and rotational devices aimed at either 
substantially removing the atheroma and/or finding a safe path through 
occlusions to allow subsequent balloon angioplasty (226-229) as well as 
balloon expandible stents to hold the vessel open (230). The Simpson 
atherectomy catheter and the transluminal extraction catheter can ex-
cise and remove atheroma from the body without the need for subsequent 
balloon dilatation but require the lesion to have been crossed by a 
guide wire first (227,228). The former is a time consuming process even 
in short segment disease and recurrences have been reported while the 
latter has only recently entered clinical use. The rotational devices 
are able to cross difficult occlusions although embolism and perfora-
tions have been recorded and they need to be followed with balloon 
dilatation (202). While the long term effects still require to be stud-
ied systematically it appears that all of these techniques exhibit an 
appreciable relapse rate ( 231). 
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Conclusions: Laser thermal probe assisted angioplasty is clearly ca-
pable of enabling successful balloon dilatation in lesions that were 
previously impassible to a guide wire and balloon system. While recog-
nised subintimal dissection using a guide wire usually prevents suc-
cessful dilatation, this is not necessarily true of the laser probe. 
The hot tip may "find" alternative routes through obstructive atheroma 
with subsequent re-entry into the distal lumen possibly being a feature 
of its mode of action. On its own, however, the laser probe does not 
produce adequate channels and the balloon remains a complimentary and 
essential part of the procedure. Larger, "hybrid", radiofrequency ther-
mal probes; sapphire tipped, lensed and spectroscopically guided laser 
systems; "atherectomy" devices and stents are all being intensively in-
vestigated at present but all the series are too small (often with con-
tinual modifications to the equipment) to allow assessment of the 
relative superiority of any of these for long term patency. For the 
majority of lesions balloon dilatation alone is possible and seems to 
be adequate. For resistant occlusions the laser thermal probe has been 
the most successful of the "newer" interventional techniques at effect-
ing recanalisation. Non-laser thermal probes, lensed, sapphire, pulsed 
and "smart" laser systems and rotational recanalisation devices have 
also been shown to be effective but convincing benefit from removal of 
atheroma in lesions amenable to balloon angioplasty remains to be shown 
for any of these techniques. 
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4 .1 INTRODUCTION 
The early negative experience with bare fibre peripheral artery laser 
angioplasty was followed by similar results after intracoronary appli-
cation. Performed at the time of coronary surgery, to enhance safety, 
the small channels produced and the competing blood flow of the con-
comitantly placed grafts ( 65) or the poor distal run off in 
non-bypassed previously occluded vessels (232) resulted in early clo-
sure of all the vessels. Only after the demonstration of clear benefit 
in the peripheral arterial system using the metal tipped laser thermal 
("hot tip") probe were percutaneous coronary artery studies first 
undertaken (174,175). 
Successful percutaneous laser thermal probe assisted coronary 
angioplasty was reported by Cumberland et al (174) and Sanborn et al 
(175) in 1986. They used modified peripheral artery probes that were 
advanced over guide wires - and all lesions were first crossed with the 
guide wire in lesions that had not previously undergone balloon 
angioplasty. While not all the procedures were successful - indeed in 
some failures subsequent balloon angioplasty was successful these 
were the first demonstrations that percutaneous delivery of laser en-
ergy could be used to vaporise coronary atheroma. 
The following studies describe the in vitro and in vivo handling char-
acteristics of laser probes in the coronary vasculature as well as the 
effects of delivering laser thermal energy both clinically and in a ca-
daver preparation. Finally an assessment of the likely developments in 
coronary laser angioplasty is made. 
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4. 2 CORONARY ACCESSIBILITY OF LASER PROBES 
While the femoro-popliteal segment is a common testing ground for as-
sessing coronary artery interventional techniques the conditions per-
taining to peripheral artery angioplasty do not necessarily apply to 
percutaneous coronary angioplasty. Modifications in probe design that 
appear necessary to facilitate coronary application extrapolated from 
the peripheral arteries may detract from the efficacy of the method and 
invalidate much of what has been learned in the periphery. The aim of 
this study was to assess the differences in currently available laser 
probes which might highlight important design features for enhancing 
safe percutaneous laser thermal probe assisted coronary angioplasty. 
(a) METHODS 
Two different peripheral artery probes in clinical use and three inves-
tigational coronary artery laser probes manufactured by Trimedyne Inc 
( Santa Ana, Calif. ) were studied using an arterial tree model and in 
cadaver hearts to assess their handling characteristics. 
(1) Probes 
1) The 2. 0 mm tip peripheral artery laser probe (Fig. 4 .1 [A]) with a 
300 um core optical fibre, a safety wire attached to the tip and a sup-
porting torque wire was the "conventional" probe used in the previous 
thermal and peripheral artery studies. 
2) The 1. 5 mm tip peripheral artery pro be (Fig. 4 .1 [ B]) had a 300 um 
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optical fibre and a more rounded eccentrically positioned tip. This has 
been used for thermal angioplasty in smaller peripheral arteries in a 
similar way to the larger version ( 173) . For intracoronary use the 
torque wire is removed to allow passage of a standard coronary 
angioplasty guide wire through the tip thus facilitating coaxial align-
ment and subsequent exchange for balloon 
(174,175). 
dilatation catheters 
3) The 1. 7 mm tip coil catheter probe (Fig. 4 .1 [ C]) consisted of a 116 
um core optical fibre contained in a flexible polyurethane cardiac 
catheter. The distal 2 cm of fibre, between the catheter and the tip, 
was enclosed in a floppy spiral metal coil further enhancing its termi-
nal flexibility. A guide wire channel passed up the length of the cath-
eter and through the centre of the tip allowing it to be advanced over 
an O. 014 inch guide wire (Fig. 4. 2) . 
4) The 1.3 mm tip coil catheter probe (Fig. 4.1 [D]) was of a similar 
design to the 1. 7 mm coil probe but the tip has a platinum coating 
aimed at reducing welding to tissue at high temperatures. 
5) The 1. 7 mm side hole tip catheter probe (Fig. 4 .1 [ E]) has a 200 um 
fibre and central guide wire channel. The tip side holes allow tip per-









Figure 4 .1: A) 2. 0 mm tip peripheral artery probe. B) 1. 5 mm tip pe-
ripheral artery probe with torque wire that can be removed 
and replaced with a coronary guide wire. C) 1. 7 mm coil 
catheter probe. D) 1.3 mm platinum coated tip coil cath-
eter probe. E) 1. 7 mm multiple side-hole tip catheter 
probe ( catheter portion identical to that of C and D but 
without the 2. 0 cm coil interspersed between the catheter 
and tip). 











Figure 4. 2: Cross-sectional diagram of the 1. 7 mm tip flexible coil 
catheter laser probe. 
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( 2) Arterial tree model 
The greater vessels in the Anatomaid Model (Meditech; USA) are made 
from clear plastic and designed to allow realistic simulation of 
percutaneous coronary artery catheterisation and evaluation of catheter 
manipulation and control characteristics. 
( 3) Cadaver heart preparation 
the 
The 
Four intact human cadaver hearts were obtained at postmortem and 
coronary ostia were cannulated with coronary guiding catheters. 
proximal 1 cm of the left main stem and right coronary arteries were 
dissected free from the epicardium to place a ligature which held the 
guiding catheter in place. The distal vessel was drained with small 
venous cannulae to allow contrast removal and prevent excessive tissue 




The 2. 0 mm laser probe was unable to pass through any of the 9F 
coronary guiding catheters although was able to pass through a 9F large 
lumen unformed guiding catheter with an internal diameter of 2. 3 mm 
( Chapter 3. 3; patient 4). When used in the model of the greater vessels 
it was found that the tip of the catheter was repeatedly displaced from 
the coronary ostium whilst the probe was advanced around the aortic 
arch due to the inflexible nature of the probe. Even when "coaxed" 
around the arch with the guide catheter tip held in the ostium it was 
unable to negotiate the last curve into the coronary ostium. The re-
maining probes however were all able to be advanced into either 
coronary artery via 8F and 9F guiding catheters from either "brachial" 
or "femoral" approaches. 
In the cadaver heart preparation the 2. 0 mm probe was unable to be ad-
vanced more than 2 to 3 cm into the proximal coronary artery segments 
without exerting considerable pressure on the vessel wall (Fig. 4.3). 
Thus in access terms alone this probe was clearly unsuitable for 
coronary use. 
The 1. 5 mm probe was able to be passed to the distal coronary vessel 
quite easily via 8F or 9F preformed guiding catheters both over the ec-
centrically placed guide wire and alone. In tortuous vessels however 
it was prone to extreme displacement of the coronary vessels (Fig. 
4.4). 
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Figure 4.3: The 2.0 mm tip probe (single arrow) is unable to pass down 
the right coronary artery in a cadaver specimen and exerts 
pressure against the wall. Guiding catheter is outlined 
and drainage cannula indicated by smaller arrows. 
117 
Figure 4.4: Control left coronary angiogram in (a). The 1.5 mm probe 
(tip shown by arrow) produces gross displacement of the 
circumflex coronary artery during advancement (b-d). The 
probe was eventually made to "turn the corner" with 
additional force. 
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Both of the coil catheter probes were very easily manoeuvred in the 
cadaver preparation and could easily access terminal branches through 
tortuous segments over the guide wire. 
The 1. 7 mm tip side hole probe catheter was not of a length suitable 
for percutaneous use (designed for intra-operative use) and was used 
with a short introducing catheter in the cadaver preparation only. It 
was easily manoeuvred in both coronary arteries but realistic simula-
tion of percutaneous delivery was not possible. 
(c) SUMMARY 
The original 2. 0 mm tip peripheral artery pro be was too large and rigid 
to access the coronary tree even if sufficiently large preformed guide 
catheters were available. The smaller 1. 5 mm version whilst able to do 
so caused marked displacement of vessels in tortuous segments limiting 
its suitability to lesions in proximal or straight segments only. The 
experimental "over the wire" catheter probes with smaller diameter op-
tical fibres were easily able to access the distal vessels without ex-
cessive displacement. Additional properties of these probes (platinum 
coating and perfusion side holes) were not assessed in this study. 
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4.3 CORONARY ARTERY LASER THERMAL PROBE ASSISTED ANGIOPLASTY 
(a) METHODS 
Laser thermal probe balloon angioplasty was attempted in three patients 
using the 1. 7 and 1. 3 mm tip flexible coil catheter probes found to 
have good handling characteristics in vitro ( Chapter 4. 2) . The study 
protocol was approved by the Guy's Hospital Ethics Committee and in-
formed consent was obtained from each patient. Originally intended as 
the pilot study for a randomised trial of balloon versus laser thermal 
probe assisted angioplasty, patients in whom balloon angioplasty had 
been or was likely to be unsatisfactory were initially included. The 
patients were prepared as for a routine balloon angioplasty but for an 
additional antithrombotic effect aspirin 300 mg 3 times/day and 
dipyridamole 100 mg 3 times/day were commenced two days before the pro-
cedure. For the second and third patients intravenous dextran and 
isosorbide dinitrate infusions were also commenced 15 minutes before 
the procedure. Prior to the angioplasty heparin 10,000 U was adminis-
tered via the arterial sheath and a temporary pacing electrode was 
placed in the right ventricular apex. 
(b) RESULTS 
Patient 1 (MW) 
A 67 year old woman with a 4 year history of angina on minimal effort 
had successful balloon angioplasty for a proximal eccentric 95% left 
anterior descending coronary artery stenosis (Fig. 4. 5 [ 1 3]). 
120 
Symptoms returned after 6 months and angiographic restenosis with a 
second less severe lesion more distally was found (Fig. 4. 5 [ 4]) . The 
remaining coronary arteries were angiographically normal with a left 
ventricular ejection fraction of 66%. A thallium perfusion scan con-
firmed reversible anteroseptal ischaemia adjacent to a fixed perfusion 
defect. She was admitted for laser assisted angioplasty whilst taking 
propranolol 10 mg 3 times/ day, diltiazem 60 mg 3 times/ day, and 
isosorbide mononitrate 20 mg twice daily. 
Angioplasty Procedure: The laser probe was first advanced via a 9F in-
troducing catheter over the guide wire through both lesions. Argon la-
ser energy was then delivered during two separate withdrawals of the 
probe, using a continuous to and fro motion, for 7 and 8 seconds re-
spectively (70 and 80 Joules). The lumen diameter improved sig-
nificantly at the primary stenosis site after "hot" but not "cold" pas-
sage of the probe but a large diagonal vessel was occluded (Fig. 4.5 
[ 6] ) . A 3. 0 mm balloon catheter ( Simpson Ul tralow Profile 3. 0 mm bal-
loon; ACS, Calif, USA) was exchanged for the laser probe over the guide 
wire and further enlarged the lumen leaving only a minimal stenosis 
(Fig. 4.5 [7 - 8]). A few minutes after the last balloon inflation she 
experienced severe chest pain and angiography demonstrated total occlu-
sion of the left anterior descending coronary artery (Fig. 4. 5 [ 9] ) . 
Intracoronary nitrates were ineffective but balloon dilatation success-
fully reopened the vessel. Patency was only short lived and the se-
quence of occlusion and reopening was repeated several times during 
which she required resuscitation with fluid, inotropes, external car-
diac massage and ventilation. She regained spontaneous output but the 
vessel remained occluded. 
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Figure 4. 5: Left anterior descending coronary artery ( right anterior 
oblique view) has a 95% stenosis (large white arrow) which 
is successfully dilated preserving the diagonal vessel 
(small white arrows) [ 1 - 3]. Recurrence of the lesion [ 4] 
is treated with the laser thermal probe (black arrow) [5] 
resulting in substantial improvement in lumen calibre but 
loss of the diagonal vessel [ 6] . Balloon inflation further 
improves the luminal calibre [ 7 - 8] but is followed by 
total occlusion (left anterior oblique view) [9]. 
Post Angioplasty Course: 
saphenous vein graft was 
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At emergency 
placed to the 
bypass grafting a single 
left anterior descending 
coronary artery. Arteriotomy confirmed absent flow without evidence of 
internal thrombosis or macroscopic charring. Whilst on cardiopulmonary 
bypass a haemoperitoneum was noted and splenectomy and repair of liver 
lacerations resulting from external cardiac massage were required to 
arrest the bleeding. The postoperative ECG revealed some loss of volt-
age with T wave inversion across the anteroseptal leads. The following 
day she had an episode of ventricular fibrillation and a second 
laparotomy was performed to remove packs left at the splenectomy site. 
She became septicaemic and died 2 weeks after the angioplasty. 
Postmortem Findings: The coronary vessels were perfusion fixed with 10% 
formaldehyde at a pressure of 100 mmHg and injected with a barium sul-
phate and gelatin mixture. Radiography revealed patency of the graft 
and at both the angioplasty sites but persistent occlusion of the di-
agonal branch. Intimal disruption and haemorrhage extending into the 
media was evident at both balloon dilatation sites on histology (Fig. 
4.6 [A]). Intimal charring with vacuolation was observed at a number of 
sites and char material blocked the origin of the diagonal branch (Fig. 
4.6 [A and B]). The left ventricle showed patchy areas of fibrosis and 







Figure 4. 6: A) Section through left anterior descending coronary ar-
tery at origin of diagonal vessel. There is considerable 
fibro-fatty atheromatous deposition and hyperplasia of the 
intima with residual intimal vacuolation. Splitting 
through to the media has occurred to the left of the fig-
ure. The lumen is filled with barium and some postmortem 
thrombus and char material is seen in the origin of the 
diagonal. Elastin-MSB - magnification X 30. 
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Figure 4. 6: B) Higher power view of diagonal origin with char obstruc-
tion. Organisation of the associated thrombus is taking 
place. Elastin-MSB - magnification X 100. 
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Patient 2 (TH) 
A 54 year old man developed angina a year after saphenous vein coronary 
artery bypass grafting. Angiography revealed a single patent graft to 
the occluded left anterior descending coronary artery and a small right 
coronary artery. The circumflex artery had a 90% stenosis proximal to 
a large marginal branch and a 70% stenosis in the distal lateral cir-
cumflex branch (Fig 4. 7 [1]). He completed 8 minutes of the Bruce pro-
tocol with chest discomfort and lateral ST. depression whilst taking 
propranolol 10 mg 3 times/day and nifedipine 5 mg 3 times/day. Revers-
ible ischaemia in the circumflex territory was confirmed by thallium 
scintigraphy and the resting left ventricular ejection fraction was 
only 33%. 
Angioplasty Procedure: Balloon angioplasty was attempted in the first 
instance and the proximal more significant lesion was successfully di-
lated (Simpson Ultralow Profile 3.0 mm balloon; ACS, Calif, USA) but 
the balloon was unable to cross the distal lesion. The laser probe was 
then advanced over the exchange guide wire but was also unable to 
progress without energy delivery. An initial tendency for the laser 
probe to displace the guide catheter was corrected by further advance-
ment of the guide catheter into the circumflex artery (Fig 4. 7 [2 
3] ) . Laser energy (argon) was then delivered on 3 occasions for 4, 5 
and 6 seconds ( 40, 50 and 60 Joules) while simultaneously attempting to 
advance the probe through the lesion. In view of the lack of progress 
despite adequate guide catheter support it was decided to abandon the 
procedure. The probe could not be withdrawn over the guide wire and 
further difficulty was encountered in withdrawing them both as a single 
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unit due to adherence of the probe tip to the vessel wall. After with-
drawal it was noted that char on the probe tip extended onto the distal 
1 cm of guide wire. Angiography showed the distal AV circumflex artery 
to be occluded with extravasation of dye (Fig 4.7 [4]). 
Post Angioplasty Course: The patient experienced chest discomfort which 
responded to opiates and echocardiography excluded a pericardia! leak. 
The creatinine phosphokinase rise and ECG changes confirmed a non-Q 
wave lateral wall myocardial infarction and at one week angiography 
showed occlusion at the laser site but maintained patency at the bal-
loon dilatation site ( Fig 4. 7 [ 5]). He experienced intermittent stab-
bing chest pain for a further two weeks which settled without specific 
treatment and the erythrocyte sedimentation rate did not rise. Three 
months later the patient was able to exercise on the Bruce Protocol to 
9 minutes without chest discomfort or ST changes and exercise was dis-
continued due to fatigue. 
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Figure 4. 7: Right anterior oblique view showing circumflex artery with 
two stenoses [1]. The proximal (small black arrow) under-
goes balloon dilatation only. During initial manipulation 
of the laser probe (open white arrow) there is displace-
ment of the guiding catheter which is overcome by advance-
ment of the guiding catheter into the circumflex artery [ 2 
- 3] . Withdrawal of the adherent probe after energy deliv-
ery reveals the distal AV circumflex to be occluded with 
dye extravasation (white arrows) [ 4]. One week later the 
proximal (balloon) site is patent but the distal branch 
remains occluded [ 5 ] . 
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Patient 3 (MC) 
A 48 year old male smoker with a three year history of angina developed 
a non-transmural lateral wall myocardial infarction. His cholesterol 
was elevated at 7. 3 mmol/1 with triglycerides of 2. 3 mmol/1 and 
bezafibrate 400 mg daily had been commenced. He could only complete 7 
minutes of the Bruce Protocol, whilst taking acebutalol 100 mg 2 
times/day, nifedipine 20 mg 2 times/day, isosorbide dinitrate 10 mg 3 
times/day, with chest pain and 1 mm ST depression inferolaterally. The 
thallium exercise scan revealed a perfusion defect in the circumflex 
territory with partial reperfusion on delayed imaging. The resting 
ejection fraction fell from 57% to 47% with stress (hand grip) and this 
was associated with hypokinesia in the posterolateral free wall. 
Angiography revealed a mildly (globally) dilated hypocontractile left 
ventricle with minor plaque disease in the left anterior descending 
coronary artery and a subtotal occlusion of a dominant left circumflex 
coronary artery (Fig. 4.8 [1]). 
Angioplasty Procedure: The coronary guide wire was easily able to cross 
the subtotal occlusion in the circumflex artery and it was elected to 
precede to laser angioplasty over this guide wire. A 1. 3 mm coil cath-
eter probe was advanced over the guide wire to the lesion and argon en-
ergy at 8 Watts was delivered for 5 seconds whilst trying to cross the 
lesion (Fig. 4.8 [2]). Despite easy tracking of laser probe over the 
guide wire there was no progress and it was decided to abandon the pro-
cedure and not persevere as in the previous patient. A 3. 0 mm Simpson 
Ultra Load Profile Balloon replaced the laser probe on the guide wire 
and after a little manipulation (including optimal positioning of the 
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guide catheter) the balloon was able to cross the lesion. The 
transtenotic gradient of 115 mmHg was reduced to + /- 10 mmHg after 8 
inflations at 6-9 atmospheres for 30-60 seconds. There was an excellent 
appearance post dilatation (Fig. 4.8 [3]). 
Post Angioplasty Course: Heparin and isosorbide dinitrate were infused 
intravenously for 24 hours as per routine and he was discharged 48 
hours after the procedure. He continued to take aspirin and 
dipyridamole and two months later completed 13 minutes of the Bruce 
Protocol without any ST changes. At elective catheterisation 6 months 
later there was a 30-40% irregular narrowing at the site of the 
angioplasty. 
(c) SUMMARY 
Laser thermal probe energy was used during percutaneous coronary 
angioplasty in three patients. In the first patient energy delivery im-
proved the lumen but this was associated with closure of an important 
side branch. After balloon angioplasty the vessel went into intractable 
spasm and emergency bypass surgery was required. The patient died of 
septicaemia two weeks later and at necropsy evidence of thermal and 
balloon dilatation damage was present. In two patients the probe was 
unable to transmit sufficient axial strength to allow recanalisation of 
the lesion during energy delivery. In one a perforation (and occlusion) 
was caused when the adherent probe was withdrawn while in the other 
balloon angioplasty was able to proceed uneventfully after the laser 
probe failure. 
130 
Figure 4. 8: Subtotal occlusion of the circumflex coronary artery [ 1] 
seen in left anterior oblique view on the left and right 
anterior oblique view on the right (open white arrow). The 
1. 3 mm laser probe (black arrow) is easily advanced to the 
lesion [ 2] but is unable to recanalise it during energy 
delivery. After balloon dilatation there is an excellent 
angiographic appearance (white arrow). Distal guide wire 
induced spasm ( small black arrows) resolves shortly there 
after [3]. 
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4.4 IN VITRO EFFECTS OF LASER THERMAL ENERGY IN CORONARY ARTERIES 
After the rather disappointing clinical results despite the seemingly 
favourable handling characteristics of the coil probes further in vitro 
studies were undertaken. It appeared essential to assess the damage 
caused to smaller vessels such as the coronary arteries before any fur-
ther clinical applications. While the handling defects of the coil 
probes were apparent from the in vivo use little quantitative informa-
tion was available about thermal effects in smaller vessels. In order 
to further assess the phenomenon of lateral wall damage during slow or 
non-progression of probes impeded by lesions, laser thermal energy was 
delivered to perfused cadaver coronary arteries with a stationary 
probe. 
(a) METHODS 
(1) Coronary artery preparation 
Cadaver hearts from patients without occlusive coronary artery disease 
obtained at routine postmortem within 36 hours of death were suspended 
in a water bath, kept at a constant 37 °c. A standard Judkins 9F 
coronary guiding catheter was positioned in the ostium of the left 
and/ or right coronary artery and the distal vessel was cannulated to 
allow continuous perfusion of the vessel being studied. Major branches 
not cannulated distally were ligated when possible to prevent excessive 
extravasation of contrast into the myocardium. The coronary segments 
were then continuously flushed with O. 9% saline at 37 °c and a mean 
pressure of 100 mmHg (Fig 4.9). 
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Figure 4. 9: Cadaver heart preparation allowing for introduction of the 




An initial angiogram using Urograffin 370 was performed to delineate 
the coronary anatomy and select disease free, non-tortuous areas for 
subsequent laser energy delivery. A 1. 7 mm tip coil laser probe of the 
type used in patients 1 and 2 was then advanced via the guiding cath-
eter over a guide wire to the selected segment. Prior to argon energy 
delivery the vessel was irrigated with saline to remove all contrast. 
One, two or three exposures of 10 Watts for 5 seconds were delivered to 
successive segments. After delivery of laser energy, the probe was 
moved to see if any adherence had occurred. A further angiogram was 
then performed to exclude any perforations and in the absence of con-
trast extravasation the probe was advanced to the next segment and the 
procedure repeated. During energy delivery the saline perfusion was ei-
ther stopped by occluding the distal drainage port (i.e. fluid disten-
sion but no flow - to mimic stasis in the proximal stump of an occlu-
sion or tight stenosis) or controlled at a rate of 60 ml per minute. 
On completion the vessel was incised longitudinally for macroscopic as-
sessment and photography. After formalin fixation the vessels were ex-
amined under a dissecting microscope and representative blocks were 
taken of visible lesions. Where a lesion was not seen the appropriate 
area was divided into several blocks and processed. Paraffin sections 
were cut and stained with haemotoxylin and eosin and a combined 
elastin-MSB stain. The angiograms were projected onto a screen and the 
vessel and probe tip diameters measured with callipers. A vessel to 
probe tip diameter ratio was then established for each segment using 
the angiogram performed immediately prior to laser energy delivery. 
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(b) RESULTS 
Laser thermal energy was delivered to 25 segments of coronary artery 
(mean diameter 2.8 mm, range 1.9-4.0 mm) in five cadaver hearts using 
four laser probes (Table II). Access to all segments was facilitated by 
the flexibility of the probe assembly. 
Adherence of the probe to the vessel wall occurred in 19 of the 25 seg-
ments in all of which the vessel to probe ratio was less than or equal 
to 2 .1 : 1. Gentle traction was successful in dislodging the probe from 
14 of these segments. Further traction alone resulted in perforations 
in two segments. The additional use of 1-2 seconds of laser energy at 
10 Watts during traction was able to free the probe in the remaining 
three albeit with a perforation in one. In all three instances where 
vessel perforation occurred, the vessel to probe diameter ratio was 
less than 1. 6 : 1 and flow through the vessel was absent. In two in-
stances the adherent probe was dislodged by traction alone while in the 
third a perforation occurred despite additional laser energy delivery 
(Fig. 4 .10). After withdrawing the probe a fracture of the distal coil 
was found (Fig. 4 .11) and it is possible that this contributed to the 
vessel perforation. Use of this probe in eight previous segments - con-
trary to the manufacturers recommendations of a single procedure use 
is likely to have weakened the coil which then dehisced either during 
placement in the coronary segment or during the initial attempted with-
drawal. 
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TABLE II RESULTS OF LASER THERMAL ENERGY DELIVERY TO CORONARY 
ARTERY SEGMENTS 
VESSEL-PROBE CUMULATIVE SEGMENT PROBE VISIBLE VESSEL 
RATIO ENERGY (J) FLOW ADHERENCE CHAR PERFORATION 
2.4 50 
2.3 50 + 
2.2 50 + 
2.2 100 + 
2.1 50 
2.1 100 + + 
2.1 150 + + 
2.0 50 + + 
1. 9 100 + * + 
1. 9 100 + + 
1. 8 100 + 
1. 7 150 + + 
1. 7 150 + + 
1. 7 100 + + 
1. 6 100 
1. 5 50 + * + + 
1. 5 50 + * + 
1. 4 150 + + 
1. 4 150 + + + 
1. 4 50 + + 
1. 4 50 + 
1. 3 150 + + 
1. 3 100 + + 
1. 2 150 + + 
1.1 50 + + + 
Results of laser thermal energy delivery to 25 cadaver coronary 
artery segments using stationary 1.7 mm flexible laser probes. 
Flow during energy delivery was maintained at a rate of 
60 ml/minute(+) or stopped i.e. 0 ml/minute(-). 
*=Use of additional laser energy during probe dislodgement 




Figure 4.10: Degree of traction necessary to free probe from right 
coronary artery. a) Preliminary angiogram. b) Laser pro be 
advanced over guide wire to posterior descending branch 
before delivery of 50 Joules. c) Marked displacement of 
vessel during traction to free probe. Large arrow indi-
cates probe tip. Small arrows show the drainage cannula. 
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Figure 4 .11: Fracture of coil found after freeing probe with traction. 
Figure 4.12: Charring of Right Coronary Artery after a cumulative total 
of 100 Joules laser thermal energy (Vessel to probe ratio 
of 2.1:1). 
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Macroscopic examination revealed charring of the endothelial surface in 
8 of the 19 adherent segments (Fig. 4.12) and in 7 of these the vessel 
to probe diameter ratio was less than 2. 0 : 1. In the remainder 
evidence of laser delivery was difficult to see even under the dissect-
ing microscope. Light microscopy identified areas in two macro-
scopically undamaged segments showing evidence of thermal damage with 
carbonisation of the luminal surface and subintimal vacuolation extend-
ing less than 0.1 mm deep (Fig 4.13). 
Charring was notably absent in all of the segments perfused simultane-
ously with energy delivery (0/12) and none required additional laser 
energy to dislodge the probe. In contrast charring was present in 8 of 
13 segments not perfused (p < 0.01). Histology of charred segments re-
vealed accentuation of the changes seen in areas where macroscopic dam-
age was not apparent. Extensive carbonisation overlay the vacuolated 
tissue which extended into the media and adventitia with a deeper zone 
of tissue eosinophilia and coagulation (Fig. 4.14). The depth of ther-
mal damage after 50 Joules ranged from 0. 2 mm in a segment with a ves-
sel to probe ratio of 1.9: 1 to 0.7 mm in a segment with a ratio of 
1.1 1. Only the angiographically perforated segments revealed 
evidence of histological perforation. 
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VACUOLATION CHAR 
Figure 4.13: Histology of area without macroscopic change showing (1) 
carbonization of luminal surface and (2) subintimal 
vacuolation. Elastin-MSB, magnification X 100. 
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Figure 4.14: Histology from a charred segment reveals (1) intimal car-
bonisation with extensive (2) vacuolation and (3) 
eosinophilic coagulation extending to the media and 
adventitia. The artifactual tissue processing split be-
tween media and adventitia is not present in the exten-
sively damaged sector. M = media, A = adventitia, IEL = 
internal elastic lamina, CE = cut edges. Elastin-MSB, 
magnification X 40. 
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(c) ADDENDUM 
During this study a cadaver preparation was found to have a subtotal 
occlusion of the left anterior descending coronary artery (Fig. 4.15). 
Argon energy at 10 Watts was delivered continuously whilst attempting 
to recanalise the lesion over the guide wire. After 10 seconds the 
force applied to the probe was further increased and the fibre snapped 
between the guide catheter haemostatic port and the operator's hand 
producing a sheet of flame (Fig. 4.16). The probe tip was adherent to 
the vessel but was withdrawn without a perforation though with unravel-
ling of the coil. On sectioning the vessel, charring was present but 
the probe had made little progress through the lesion (Fig. 4.17). 
TRFURCA TION 
VESSEL 
Figure 4 .15: a) Tight stenosis of the left anterior descending coronary 
artery (LAD) proximal to the origin of a large diagonal 
(LADD) branch with attempted advancement in b). 
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10mm 
Figure 4 .16: Disrupted catheter edges at site of fibre fracture with 
guide wire traversing the gap. 
Figure 4 .17: Charring at the site of the stenosis after energy 
delivery ( circled area from angiogram Fig. 4 .15) . 
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(d) LIMITATIONS OF THE MODEL 
The laser probes were heated in a saline medium and as blood is a bet-
ter insulator (191, Chapter 2) the probe temperature would have been 
higher and damage more marked at the flow rates used. In vivo the 
greater tip temperature might thus diminish the degree of protection 
seen with flow in this study. If blood had been used as a perfusate 
this would have allowed only a single use for each probe as char and 
thrombus formation would have altered the thermal transfer with succes-
sive applications ( Chapter 2). The specific heating and insulation 
properties of myocardium and pericardia! fat are likely to be different 
in vivo but by leaving the vessel in situ this model is more realistic 
than if the vessels had been dissected and suspended free from the 
heart. Flow in coronary vessels with severe stenoses will be low and 
will fall further when the advancing probe occludes the effective 
lumen. Thus the controlled flow rate of 60 ml/minute is unlikely to be 
attained in vivo. Nevertheless the difference in effects that can be 
expected during conditions of stasis and normal flow suggest that rapid 
passage of the probe across a lesion to re-establish flow will help to 
limit damage. Clearly total occlusions impeding probe passage will 
present the greatest challenge (but so too did the high grade stenoses 
in patients 2 and 3) and it was for this reason that the effects during 
complete stasis were studied. While the leading edge of the probe tip 
was not in vessel wall contact it was not possible to be certain how 
firmly the lateral aspect of the probe tip was applied to the vessel 
wall. Anatomical factors including vessel tortuosity and distance down 
the vessel would have determined the degree of lateral contact and con-
sequent vessel damage (102). This may explain why the amount of deliv-
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ered energy was not absolutely correlated with the observed effects. 
Electron microscopy might well have revealed evidence of thermal damage 
in some segments with adherence and no apparent light microscopy 
changes though it is unlikely that significant intimal damage would 
have been missed. While the probe tip temperature was not measured dur-
ing this study it is unlikely that vessel wall contact would have been 
identifiable by higher temperatures ( Chapter 2). 
(e) SUMMARY 
Laser thermal energy delivered to stationary probes in cadaver coronary 
arteries was found to cause thermal damage at energies as low as 50 
Joules. Adherence to the lateral wall was common but did not always im-
ply macroscopic damage. Macroscopic damage however was only present 
when vessels were not perfused during energy delivery. Where gentle 
traction failed to free the probe significant lateral wall adherence 
was present. All three segments which perforated had vessel to probe 
tip diameter ratios less than 1. 6 : 1. In two traction alone was used 
to dislodge the probe tip and was clearly excessive. The use of sup-
plemental laser energy during further sustained traction is likely to 
have prevented perforation in two segments where the tip was firmly 
adherent. In the third perforation however even this step was un-
successful and the perforation may have been caused by dehiscence of 
the coil which then embedded itself into the vessel wall. Further 
evidence of the un&aitability of this probe design was found in a 
single stenotic lesion where the flexible probe could not be advanced 
through the lesion during energy delivery and the fibre proximal to the 
guide catheter snapped during attempted forceful advancement. 
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4.5 DISCUSSION 
Laser thermal probe assisted angioplasty as a means of overcoming some 
of the limitations of the conventional balloon procedure is clearly a 
viable manoeuvre in peripheral arteries ( Chapter 3. 4) . The extension of 
this procedure to coronary arteries has not met with the same degree of 
success (174,175, Chapter 4.3) and needs to be reappraised in the light 
of coronary anatomy and the currently available delivery systems. 
Furthermore its role in coronary artery disease is yet to be defined in 
the current setting of modern balloon angioplasty techniques. While in-
ability to primarily dilate lesions which have been crossed with a 
guide wire or repeated recurrence after initial successful balloon 
dilatation are now uncommon, acute occlusions and a recurrence rate of 
20-40% are unresolved problems ( 233-235). Reliable percutaneous treat-
ment of total occlusions (as is now possible in peripheral arteries 
with contact laser techniques) is only possible in recent occlusions 
and distal endarterectomy, either percutaneously or as part of bypass 
grafting, remains a speculative goal. It is in these areas that laser 
assisted angioplasty has to demonstrate superior results for it to be 
accepted clinically. 
The effectiveness of percutaneous laser thermal probes (as well as 
sapphire, lensed and spectroscopically guided systems) in peripheral 
vessels cannot automatically be extrapolated to the coronary circula-
tion. In peripheral artery angioplasty the distance from the 
percutaneous access point to the lesion is usually short and the ves-
sels are straight, of large calibre and motionless. Substantial axial 
force may be used during advancement and while not quantifiable 
146 
clinically this force has been shown to increase the degree of ablation 
with contact laser systems (102). This might simply reflect improved 
heat transfer due to better thermal coupling but thermal compression of 
the heated area could also be responsible. In addition delay in ad-
vancement and adherence to the lateral wall is uncommon as the proxim-
ity to the lesion allows a more rapid to and fro motion during advance-
ment. 
Intracoronary "hot tip" laser assisted angioplasty is however, techni-
cally more demanding. Smaller probes incorporating a greater degree of 
flexibility are required for percutaneous access through preformed 
guiding catheters. Access, however, is not the only criterion for suc-
cessful coronary artery laser recanalisation. Sufficient axial strength 
to enable progression through the lesion but without excessive trauma 
to the vessel - either mechanical or thermal is also essential. Thus a 
probe that is able to access the coronary tree but is nevertheless too 
rigid, may still damage the vessel. The earliest probes designed for 
the peripheral circulation were too large and inflexible for use in the 
coronary tree. The smaller peripheral artery probes ( 1. 5 1. 7 mm 
tips) were modified by creating an eccentric guide wire channel through 
the tip itself to facilitate coaxial advancement and subsequent balloon 
exchange. Suitability was limited to proximal portions and straight 
coronary segments. Three studies of percutaneous coronary laser ther-
mal angioplasty using this type of probe have been performed with mixed 
results (174,175,190). 
During a per-operative coronary artery study using cumulative 




initially successful cases. Competing flow from the concomitantly 
placed bypass grafts is likely to have contributed to these early oc-
clusions (190). This is not inevitable as in a single case report of 
intra-operative laser probe use (with a more flexible device), both the 
graft and treated vessel were patent at a week ( 236). Two percutaneous 
"over the wire" laser thermal probe coronary artery studies using the 
adapted peripheral artery probes ( energies of 40-80 Joules) have been 
reported. In neither series were acute complications encountered al-
though in the larger one inability to recanalise the lesion occurred in 
3 out of 7 patients ( 175). In the smaller series 1 patient of the 4 
had a transmural myocardial infarction and 2 patients had enzyme rises 
all occurring within 24 hours of the procedure (174). Clearly spasm, 
thrombosis or embolism from the laser sites could be implicated al-
though it would be impossible to exclude balloon angioplasty related 
complications. It was for this reason that aspirin and dipyridamole 
were added to the angioplasty regimen for the patients studied here. 
In the first patient a large diagonal vessel close to the left anterior 
descending coronary artery stenosis was occluded during energy delivery 
before balloon dilatation. The finding of char in the origin of the di-
agonal vessel at postmortem confirms that the thermal effect in the 
smaller coronary vessels is not as innocuous as it seems to be in the 
peripheral circulation. The subsequent occlusion is likely to have 
been caused by spasm at the site of the lesion although clearly both 
thermal or balloon dilatation damage could be implicated. Repeated 
coronary spasm has been seen in canine coronary arteries during laser 
thermal energy delivery though not with similar amounts of pulsed en-
ergy (134). The avoidance of excessive thermal damage is thus critical 
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and demands the minimum of energy necessary to recanalise the lesion. 
The probe tip size is important: in the saline perfused cadaver 
coronary arteries , vessel to pro be diameter ratios of > 2. 0: 1 were 
needed to reliably avoid thermal damage. While "flowing" saline was 
protective in this model the greater temperatures attained in blood (at 
least initially - Chapter 2.4) may demand an even smaller tip size. 
Hence to be applicable at most common balloon angioplasty sites, probes 
with tip diameters less than 1. 3 mm are required. If the primary aim 
of the procedure however is only to make the first channel to enable 
subsequent balloon angioplasty then even smaller probe tips will be ac-
ceptable and should reduce the extent of thermal damage. 
While excessively rigid probe may prevent or limit percutaneous use to 
proximal and straight segments, at the other end of the spectrum, ex-
cessively flexible probes, will lack axial strength to facilitate ad-
vancement (patients 2 and 3 and cadaver stenosis) despite the ease of 
access. Non-advancing probes are prone to welding to the vessel wall 
either proximal to or at the lesion site (190). Perforation, par-
ticularly on dislodgement may occur and thermal damage might possibly 
increase the risk of spasm and thrombosis. While perforations using the 
laser probe are uncommon both experimentally (168,171) and clinically 
(173,203, 204-209) they have tended to occur either with non-coaxial ad-
vancement or when excessive force is used with calcified and eccentric 
plaques (210,211). The flexible probes used here are unable to transmit 
excessive force and perforations due to a different mechanism were ob-
served i.e. forceful dislodgement of adherent probes. Until the devel-
opment of a probe tip surface that does not adhere to tissue at high 
temperatures it would seem that delivery of a small amount of laser 
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energy together with further gentle traction is the best action in this 
setting. Attempting to advance adherent probes, already held up at the 
site of a lesion, during additional laser energy delivery, is likely to 
cause further lateral wall damage. The perforation encountered in the 
second patient (and the accompanying occlusion) is evidence of such un-
wanted thermal effects. Tamponade may have been prevented by 
pericardial adhesions from the previous bypass grafting procedure or by 
thrombogenicity of the severely damaged segment (i.e. a cauterising ef-
fect). In the intra-operative study of percutaneous "hot tip" laser 
angioplasty using adapted peripheral artery probes a perforation oc-
curred during advancement but was contained in the epicardial fat 
(190). Whilst the primary problem in this patient was clearly that of 
imperfect catheter probe design it highlights the danger in delivering 
excessive thermal energy in the coronary system. Finally percutaneous 
endarterectomy of distal vessels, an additional postulated role for la-
sers in coronary artery disease, is unlikely to be successful with "hot 
tip" probes. Nevertheless such a procedure performed intra-operatively 
without the constraints of the delivery systems and where spontaneous 
termination of spasm could be awaited with safety might yet succeed. 
The results of the in vivo applications here with the highly flexible 
probes, together with the subsequent cadaver studies suggested that 
thermal probes might only be suitable for "pilot hole" recanalisation 
prior to balloon dilatation. Extensive "debulking" procedures or distal 
endarterectomies appeared likely to be deleterious if performed 
percutaneously. Cumberland has since been able to cross three out of 
four total coronary occlusions that could not be crossed with a guide 
wire, using an 0.18 inch thermal probe capped guide wire (237). The 
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vessel to probe diameters with this system approach those seen in pe-
ripheral artery laser thermal angioplasty thus increasing the safety 
margin. 
The in vivo and in vitro experience here together with that of others 
has led to further coronary thermal probe design modifications (238). 
The optical fibre in coil catheter probes has been increased to a diam-
eter of 200 um while similar catheters without a coil have been made, 
both measures reducing the unwanted excessive flexibility. In addition 
the side hole tip probe catheter has been produced in a length for 
percutaneous use. Preliminary reports of a multicenter study in 47 pa-
tients including both native vessel and vein graft stenoses ( 11 recur-
rent after balloon angioplasty) have been more successful (239,240). 
Detachment of the probe in one patient (model without safety wire) was 
fatal after emergency bypass surgery; in four the probe could not cross 
the lesion but balloon dilatation was successful in three - a similar 
setting to patients two and three here; there was one acute closure and 
17 re-stenoses within six months for only a 49% success rate over six 
months ( 57% of successful procedures). While careful attention to se-
lection criteria, pre and post angioplasty anticoagulation and 
antispasm regimes, and improved catheter probes have clearly improved 
the technical success rate, obvious benefit over balloon angioplasty is 
not apparent. 
A move to enhance thermal "de bulking" by using larger pro be tips ( 1. 9 
mm) heated more rapidly ( 15 Watts) has been made very recently. It is 
postulated that the delivery of heat in this fashion will cause more 
vaporisation without time for much thermal diffusion and therefore 
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excessive injury or spasm as seen with the smaller metal tipped probes. 
In two patients (one native coronary artery and one vein graft) the 
procedure was reported to be successful producing channels that did not 
need subsequent balloon dilatation (241). It is of course possible 
that rather than lessening thermal injury the more intense heat is able 
to coagulate the muscle completely so that the spasm potential is re-
duced. Interestingly the radiofrequency "hot tip" probe catheters have 
also been shown to be successful in a small clinical report ( 242) . 
Laser balloon angioplasty (using a diffusing tip to deliver Nd-YAG en-
ergy through a balloon to seal balloon dilatation trauma - Chapter 1. 7) 
intentionally thermally coagulates the whole vessel wall. Applied at 
the end of a standard coronary balloon angioplasty procedure, insuffi-
cient studies have been done to allow an assessment of the impact on 
acute closure and restenosis ( 243). The preliminary results, however, 
do indicate that restenosis is not abolished with this technique (244). 
Further competition for the laser based technologies may come from the 
development of radiofrequency heated balloons which have yet to be ap-
plied clinically ( 245) . 
Since the use of pulsed excimer energies in peripheral arteries for to-
tal occlusions, an "over the wire" system has also been used in a pa-
tient with coronary artery disease though balloon angioplasty was still 
required ( 246). Perhaps the most impressive work is that of Foschi et 
al who have used a lensed argon fibre ( Chapter 1. 7) to cross total oc-
clusions without the benefit of a guide wire (247). In 25 of 27 pa-
tients, lesions through which a guide wire could not be passed, 




balloon angioplasty. While it is too early to tell what the restenosis 
rate with this technique will be (and already 5 recurrences have oc-
curred) it is highly encouraging that lesions that would not have been 
amenable to conventional balloon angioplasty have been successfully 
treated. 
Finally the "atherectomy" and "extractor" catheters, and rotational 
devices are also beginning to be applied in coronary arteries 
(228,248). The former two require guide wires but the latter may also 
be used in total occlusions. Coronary artery stents have come to play 
a role in lesions with acute closure immediately after angioplasty or 
where recurrent stenoses have occurred but seem to be accompanied by a 
restenosis rate similar to that of conventional angioplasty (249). 
Still on the horizon is the use of ultrasonic energy to accomplish 
atheroma ablation (250). 
Conclusions: The "hot tip" laser thermal probe has not been as success-
ful as its peripheral artery counterpart though both smaller diameter 
probes (causing less vessel damage) and larger diameter probes (perhaps 
completely coagulating the vessel wall) have shown some promise. The 
laser balloon which uses a non-ablative thermal mechanism to maintain 
the dilatation effected by balloon angioplasty has also been shown to 
be useful. More sophisticated systems including the pulsed excimer and 
in particular the lensed argon systems have been shown to be safe and 
practical. None of these laser systems (nor indeed any of the newer in-
terventional techniques) have yet been shown to reduce the recurrence 
rate. Further development of the existing technologies and the 
clinical application of multifibre, spectroscopically guided pulsed la-
sers are awaited. 
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5 .1 INTRODUCTION 
Percutaneous direct current catheter ablation of the Bundle of His has 
revolutionised the management of patients with otherwise uncontrollable 
supraventricular arrhythmias (251,252). Successful ablation is now 
achieved in over 60% of cases with single or multiple high energy 
shocks (253). In addition "modification" of AV nodal conduction occurs 
in a further 15% so that medical control of the arrhythmia becomes pos-
sible. High energy shocks have since been used to ablate accessory 
pathways (254,255), as well as atrial ( 256) and ventricular 
arrhythmogenic foci (257,258), although with lower success rates and a 
higher tendency for complications including coronary sinus rupture 
acutely and late ventricular arrhythmias or sudden death (255,258). 
These complications have prompted the search for more controllable en-
ergy delivery systems or sources. A number of avenues using "low en-
ergy" direct current shocks have been tried but without consistent suc-
cess (259-261). Radio frequency energy can be applied without the need 
for general anaesthesia and successful ablation has been reported re-
cently (262,263). The development of flexible optical fibres capable of 
being passed down vascular catheters has led to the application of ar-
gon and Nd-YAG laser energy for ablation of the bundle of His with the 
ability to produce localised lesions in dogs ( 71, 72,264,265). A 
separate electrode placed at the bundle of His, however, is necessary 
to guide the laser fibre prior to energy delivery. This is an 
unsatisfactory approach as alignment can only be approximate and 
control of the emergent energy resulted in cardiac perforations 
poor 
and 
tamponade (71). The laser thermal probe has not previously been used 
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for His Bundle ablation but has the advantage that electrograms can be 
recorded from the metal cap itself obviating the need for an additional 
guiding electrode. 
The following studies were designed to: 
1) Assess the degree of damage caused by the laser thermal probe when 
applied to the bundle of His area and adjacent intracardiac struc-
tures in cadaver hearts. 
2) To confirm that the metal cap could be manoeuvred adjacent to the 
bundle of His and record electrograms of sufficiently good quality. 
3) To perform laser thermal probe ablation of the bundle of His in pa-
tients with refractory supra ventricular arrhythmias. 
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5.2 METHODS 
(a) Laser probes 
The standard peripheral artery laser probe with a 300 um optical fibre 
capped by a 2. 0 mm diameter metal tip was used for these studies. For 
clinical use the probe was adapted by sheathing the torque wire with 5F 
C d "head hunter" 1t· th t (F' 5 1) This ournan , or mu 1purpose ca e ers 1g. . . 
provided insulation so that extraneous electrograms were not recorded 
and also enhanced the control of the laser probe assembly during 
intracardiac manipulation. 
(b) Cadaver hearts 
Fresh cadaver hearts were obtained at routine postmortem and suspended 
in a water bath controlled at 37 °c. The laser probe tip was applied 
sequentially to the tricuspid annulus at the base of the triangle of 
Koch, the AV membranous septum, the Foramen Ovale, the right atrial ap-
pendage, the septal leaflet of the tricuspid valve, the 
interventricular septum, and the right ventricular free wall. Argon en-
ergy at 10 Watts for 5, 10 and 15 seconds ( 50, 100 and 150 Joules) was 
delivered to all these sites using gentle pressure. Where tissue adher-
ence did not allow easy dislodgement of the probe an additional 1-2 
seconds of energy was delivered during sustained traction to free the 
probe. The lesions were photographed and histological analysis per-
formed on sections taken through the centre of each lesion. 
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(c) Patients 
The adapted laser probe was evaluated during diagnostic 
electrophysiological studies. The probe was advanced through a 9F 
haemostatic sheath via the right femoral vein to the right atrium, 
right ventricle and into the His bundle position. Unipolar 
electrograms (indifferent needle electrode placed subcutaneously at 
femoral vein puncture site) were recorded and compared to those ob-
tained with standard electrophysiological catheters. 
In a patient with refractory paroxysmal atrial fibrillation, His bundle 
ablation was attempted using the modified laser probe. The protocol was 
approved by the Guy's Hospital ethical committee and written informed 
consent was obtained. 
Figure 5 .1: 2. 0 mm diameter tip probe with support wire sheathed in a 
5F multipurpose catheter for in vivo use. 
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5.3 RESULTS 
(a) Cadaver hearts 
Charred craters were created at all sites with all three energy levels 
in 9 cadaver hearts (Table III). The crater diameter varied from 1.5 
mm to 2. 2 mm on the surface with smaller craters in muscular structures 
than in fibrous structures. Even when the probe passed completely 
through the right ventricular free wall and interventricular septum the 
tract diameter was always less than 2.0 mm. The more fibrous atrial 
free wall, interatrial septum, tricuspid valve leaflet and AV membrane-
ous septum frequently exhibited transmural charring (Figs. 5. 2 A - D). 
During some of the longer applications the leading edge of the tip per-
forated these structures but the opposite surface lesion was always 
less than 1. 0 mm in diameter. Close inspection of transmurally charred 
lesions did not reveal obvious perforations. Histology of these lesions 
confirmed transmural thermal damage and in some minor perforations were 
apparent though preparation artefact could not be excluded. The 
tricuspid annulus was never perforated with the energies used. Histol-
ogy confirmed the typical changes of thermal damage: a thin layer of 
char lined the crater and covered an area of vacuolation below which 
was a variable zone of tissue coagulation. Five second bursts were in-
adequate to significantly damage the Bundle of His (Fig. 5. 3 A) whilst 
10 - 15 seconds bursts produced craters to a sufficient depth (Figs. 
5. 3 B and C). It was noteworthy that the zone of thermal coagulation 
was still able to damage the Bundle of His even when the crater was 
slightly off target. 
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Table III 
SITE TIME n TRANSMURAL PERFORATION 
CHAR 
Foramen Ovale 5 sec 9 2 
10 sec 9 7 
15 sec 9 6 3 
Right Atrial Appendage 5 sec 9 
10 sec 9 5 
15 sec 9 7 2 
Tricuspid Valve Leaflet 5 sec 9 7 
10 sec 9 7 
15 sec 9 4 5 
Interventricular Septum 5 sec 9 1 
10 sec 9 2 2 
15 sec 9 1 8 
Right Ventricular Free Wall 5 sec 9 
10 sec 9 2 
15 sec 9 5 4 
AV Membranous Septum 5 sec 3 3 
10 sec 3 3 
15 sec 3 2 1 
Tricuspid Annulus 5 sec 9 
10 sec 14 
15 sec 19 
Effects of laser thermal energy of 50 - 150 Joules (5 - 15 seconds 




RIGHT A TRIAL APPENDAGE 
Endocardium Epicardium 
5 sec burn 
10 sec burn 
FORAMEN OV ALE 
Right Atrial Surface Left Atrial Surface 
5 sec burn 
15 sec burn 
Figure 5. 2: Examples of the craters produced during laser thermal en-




TRICUSPID VAL VE LEAFLET 
Atrial Surface Ventricular Surface 
15 sec burn 
"TRIANGLE OF KOCH" 
Coronary Sinus 
Left Heart Aspect 
( 1 o sec burn) 
Figure 5. 2: Examples of the craters produced during laser thermal en-
ergy delivery at 10 Watts 
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Figures 5 . 3: In this and the next 2 panels the bundle of His is en-
closed in dotted lines while the extent of thermal damage 
is delineated with a solid line (i.e. crater, surface 
char, tissue vacuolation and thermal coagulation zone) . 
TVL = Tricuspid Valve Leaflet, IVS = Interventricular 
Septum. Haematoxylin and Eosin; magnification x 40. 
(a) 5 second crater (10 Watts) is not deep enough to dam-




(b) 10 second crater (10 Watts) to the correct depth is 
not directly above the bundle of His. The thermal coagula-
tion zone how ever extends to encompass a portion of the 
bundle. 
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Figures 5.3 (c) 10 second application (10 Watts) partially vaporises 
bundle of His with additional thermal coagulation beyond 
the crater limits. 
165 
(b) Electrophysiological studies 
In three patients undergoing electrophysiological studies ( a woman aged 
26 with supra ventricular tachycardias, and a woman of 56 and a man of 
63 undergoing standard direct current His bundle ablation) the modified 
probe assembly was easily manoeuvred into standard electrophysiological 
positions despite being slightly less flexible than 5F and 6F USCI bi-
polar electrodes (Fig. 5. 4). The unipolar electrograms closely matched 
those of the conventional electrodes although the laser probe was more 
susceptible to alternating current interference (Figs. 5. 5 a and b) . 
Figure 5. 4: Modified laser probe and 6F bipolar electrode catheter in 
1) right atrium, 2) right ventricle, 3) His bundle posi-
tion, 4) Laser probe in His position and bipolar catheter 
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Figures 5. 5 Surface and intracardiac electrograms accompanying: 
a) Fig 5.4 panel 3 and b) Fig. 5.4 panel 4. 
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(c) Percutaneous His bundle ablation 
A 60 year old woman (JS) with the sick sinus syndrome experienced nu-
merous disabling attacks of paroxysmal atrial fibrillation. Treatment 
with digoxin, propranolol, disopyramide, quinidine and amiodarone sin-
gly or in combination had been ineffective or caused side effects 
(photosensitivity on an adequate amiodarone dosage). The frequency of 
palpitations 
began to 
had been increasing over 9 years to the point where she 
experience two to three attacks per day lasting from a few 
minutes to hours and disturbing her by the rapid erratic palpitations. 
During tachyarrhythmias she had occasional dizziness but no true syn-
cope. Repeated 24 hour Holter monitoring had revealed numerous 
episodes of atrial flutter and fibrillation with rates of up to 150-170 
beats per minute as well as bradycardic episodes with rates as low as 
35 beats per minute in sinus rhythm. Despite the bradycardic episodes 
symptoms were always clearly attributable to her rapid palpitations. 
She was admitted for His bundle ablation and agreed to participate in a 
study of the efficacy of the laser thermal probe for this purpose. 
Laser His Bundle Ablation: Using local anaesthesia a 5F bipolar tempo-
rary pacing lead was passed from the right femoral vein to the right 
ventricular apex. A 2. 0 mm peripheral artery laser probe with its 
torque wire sheathed in a 5F Cournand catheter was then advanced via a 
9F haemostatic sheath in the right femoral vein to the His bundle posi-
tion. Adequate unipolar His bundle electrograms were recorded via the 
thermal probe but it was immediately apparent that the probe tip was 
only "resting" against the AV septum. Laser thermal energy from the 
Nd-YAG generator at 12 Watts for 10 seconds was delivered without any 
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apparent effect. During energy delivery however the intracardiac signal 
displayed marked interference (Fig. 5. 6). The laser probe was then 
withdrawn, char cleaned off the tip and the Cournand insulation sheath 
replaced with a 5F "head hunter" catheter. At the same time the collar 
of the laser probe was angulated - both the latter manoeuvres aimed at 
enhancing tissue contact. The probe was re-advanced and after obtain-
ing a good signal albeit again without firm tissue contact 12 Watts for 
15 seconds was delivered without affecting conduction. After 
decharring the probe the final energy delivery sequence at 12 Watts for 
30 seconds was delivered but once again without any effect. At no time 
did the patient experience discomfort during the delivery of energy. 
Withdrawal of the probe through the introducer sheath on this occasion 
proved to be complicated. It became apparent that more torque wire 
than optical fibre had been withdrawn but it was difficult to advance 
the torque wire at this point and withdrawing the optical fibre re-
sulted in it fracturing at the point of attachment of the safety wire. 
It was then only possible to remove the torque wire, tip and residual 
optical fibre still attached to the tip, by simultaneously removing the 
introducer sheath and dissecting down from the puncture site to the 
vein entrance point. Review of the cine-frames revealed that wide 
separation (and hence disparate advancement) of the radiolucent optical 
fibre and the torque wire had occurred during manipulation ( Fig 5. 7) . 
A 6F bipolar electrode catheter was then advanced through the right 
femoral vein into the His bundle position and after the induction of 
general anaesthesia a single 300 Joule shock produced complete heart 
block. Just prior to pacemaker implantation the following day she sud-
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denly resumed sinus rhythm and a further conventional His bundle abla-
tion shock produced complete heart block albeit only for 24 hour again. 
She remained in first degree AV block and subsequently a ventricular 
demand pacemaker set at a back-up rate of 50 beats per minute and low 
dose amiodarone (100 mg daily) were able to maintain her free from 
symptomatic tachycardias without precipitating undue bradycardias or 
drug side effects. 
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Surface and intracardiac signals (laser probe) during at-
tempted laser thermal ablation of the bundle of His. 
170 
Figure 5. 7: Cine-frame during intracardiac manipulation reveals wide 
separation of the catheter containing the support wire and 
the optical fibre. The curved white arrow indicates the 
point of attachment of the safety wire to the optical fi-
bre. The straight arrow points to the probe tip in the His 
bundle position. (A surface electrode partially obscures 
the temporary pacing lead) 
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5. 4 DISCUSSION 
Narula and colleagues first used argon laser energy to ablate portions 
of the AV node in dogs and were able to produce discrete areas of 
tissue damage which led to modification of AV nodal conduction. They 
used a bare 200 um fibre housed in a 7F angiographic catheter which was 
positioned in close proximity to a bipolar 5F electrode catheter placed 
in the His bundle position. Argon energy of 2. 5 Watts for 90 seconds 
( 225 Joules) produced complete heart block in one out of three dogs 
whilst in the remaining two perforation with tamponade occurred (71). 
Macroscopic analysis revealed a 3 x 4 mm area of damage in the His 
bundle area with a zone of haemorrhage on the left heart surface. In a 
subsequent series using lower energies (0. 7-1.4 Watts for 10 90 
seconds) 1st to 3rd degree AV block was obtained and persisted in 6 
dogs to follow-up at four weeks ( 72). Subsequent studies by Weber 
using Nd-YAG energy (264) and Curtis et al using argon energy (265) 
have also been successful at causing heart block in canine prepara-
tions. 
Accurate location of the bundle of His before the delivery of ablative 
energy is essential and must apply to direct current and all other en-
ergy sources. It is only by so doing that the minimum effective energy 
can be decreased thereby preventing the deleterious effects of exces-
sive or poorly directed energy. In clinical practise the size of the 
His bundle spike and the relative sizes of the atrial and ventricular 
signals are used to indicate the proximity of the recording electrode 
to the His Bundle. Positioning radiolucent bare optical fibres near to 
a reference electrode would be imprecise even with biplane radiographic 
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imaging. Even if the fibre was close to the electrode the angle of in-
cidence of the fibre tip with the target could not be predicted with 
any degree of certainty and this might account for the tamponade seen 
in the earlier study (71). 
Weber used a bare fibre housed in a catheter with a distal ring elec-
trode to enhance localisation and no perforations occurred as long as 
the fibre tip was kept in the catheter (264). If, however, the recorded 
electrogram is not from the very tip of the electrode, but from its 
side, then the fibre will still not be aligned with the target. The 
current technique for recording the His bundle electrogram in humans is 
by withdrawal of an electrode from the right ventricle so that the 
leading edge is unlikely to be adjacent to the His bundle. To overcome 
this problem Curtis inserted the ring electrode catheter with its fibre 
via an atriotomy (265). This enabled the fibre to be aligned perpen-
dicularly to the bundle of His and only microscopic ( haemodynamically 
insignificant) perforations were seen in the AV septum. In 5 of 6 dogs 
complete heart block was achieved with 3-15 applications of energies of 
30 - 90 Joules. In using this technique these energy parameters do not 
necessarily apply to percutaneous delivery of energy. Weber has further 
modified his approach by including retractible prongs on the distal 
ring electrode to grip the endocardium at the electrophysiologically 
directed target ( 266) . As yet this has only been used for ablation of 
ventricular myocardium in a canine model. A number of centres are cur-
rently using lasers (argon, Nd-Y AG and even excimer) for ablation of 
myocardial arrhythmogenic foci (267-270). These are performed under di-
rect vision intra-operatively and rely on non-vaporative thermal in-
jury to irreversibly destroy these foci. The precise application and 
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absence of a blood medium do not allow these energy parameters to be 
extrapolated to percutaneous energy delivery. 
In using the radio-opaque metal tipped laser probe both energy delivery 
and localisation are obtained with the same device so that accurate de-
livery of energy does not rely on positioning the energy delivery sys-
tem adjacent to a separate bundle of His locating system. Furthermore 
the laser energy is confined to the probe tip so that remote cardiac 
perforations should be avoided while at the energies used damage in the 
His bundle area would be limited. The cadaver study served as a pre-
liminary feasibility approach to the in vivo application of laser ther-
mal probe His bundle ablation. While the study was performed in saline 
which limits probe tip temperatures to around 100 °c (Chapter 2), in 
flowing blood at rates of 1 litre/minute similar temperatures are ob-
served (191), so that thermal damage effects should be comparable. Per-
foration tract diameters were not measured in an intact pressurised 
heart and might therefore be greater in vivo while lesions showing 
transmural charring only might have been converted to perforations un-
der pressure. Even so septal and tricuspid perforations are unlikely to 
be of clinical importance if the probe was marginally misdirected in 
vivo, though this cannot be said for the free wall lesions. The depth 
of damage is also related to the force applied (102): this was not 
quantified this but pressure "similar" to that used in positioning 
intra vascular electrodes was used. Precise application of the probe tip 
was possible in vitro but without modification to the delivery system 
application of the side of the tip rather than the leading edge might 
occur resulting in a wider but more shallow area of damage and only 
"modification" of AV nodal conduction. 
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The in vitro studies had seemed to suggest a promising technique for 
accurate delivery of discreet amounts of energy at the His bundle but 
the extension to the in vivo situation proved to be disappointing. 
While there was no difficulty in recording a good His bundle signal 
this clearly did not equate with precise enough application of the tip. 
It was also clear that the energy parameters might be underestimates 
for in vivo application and thus a higher power was used for longer pe-
riods. This adaptation of the peripheral artery laser probe is there-
fore clearly not suitable and a dedicated probe with a shape designed 
to maximise pressure at the His bundle is required. In addition to ob-
viate any potential "bow stringing" of the separate optical fibre and 
torque wire it would be necessary for them both to be incorporated in a 
single catheter. 
Narula et al have recently developed a similar system using a metal 
tipped catheter which is "preshaped" to locate the Bundle of His. The 
same metal tip is then heated using electrothermal energy but has only 
been used to partially modify AV nodal conduction according to a pre-
liminary communication ( 271). Although marginally more effective than 
the laser thermal probe in the patient studied here, it would appear to 
suffer from the same limitations. Thus accurate "location" of the 
bundle of His does not necessarily imply sufficient contact and it is 
this factor which is the greatest hurdle to safe and effective low en-
ergy His bundle ablation whatever the energy source. 
Conclusions: His bundle ablation using the metal tipped laser thermal 
probe was possible in cadaver hearts and energy delivery produced lo-
calised lesions. The probe itself was capable of being used to locate 
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the bundle of His by obtaining good quality unipolar electrograms. Ob-
taining an adequate His bundle electrogram however, does not imply ad-
equate contact of the electrode with the endocardium overlying the 
bundle of His. Quite clearly this is the limiting factor in all forms 
of percutaneous His bundle ablation and argues for innovative measures 
to enhance delivery of energy much more closely to the His bundle. 
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CONCLUSIONS 
The work in this thesis confirms the "hot tip" laser thermal probe to 
be clinically useful in peripheral angioplasty where it enables balloon 
dilatation of lesions previously impassable to a guide wire and balloon 
system. The channel produced by the laser thermal probe (and indeed by 
other devices such as the sapphire tip, lensed argon and pulsed lasers) 
are in themselves inadequate at present. Extension of these techniques 
to patients with lesions amenable to primary balloon dilatation is cur-
rently not justifiable, in the absence of evidence that their use can 
reduce the recurrence rate compared to balloon angioplasty alone. Pro-
spective randomised treatment trials are now urgently required in this 
area to evaluate the importance of "debulking" atheroma. Radiofrequency 
heated probes may also prove to be as effective as the laser heated 
probes with the advantages of lower cost, easier portability and (user) 
safety. Other more sophisticated laser systems and non-laser interven-
tional devices are still being investigated but have not achieved the 
clinical status of the laser probe in peripheral vascular disease. 
In the small number of patients with coronary artery disease treated 
here the laser thermal probe was not found to be very effective. While 
others have since had better results using slightly different equipment 
even these are only as much as would be expected with current coronary 
balloon angioplasty techniques. For total occlusions the use of very 
narrow diameter probe tips may allow safe "pilot hole" recanalisation 
to facilitate subsequent balloon dilatation. This would in many ways 
resemble the ( successful) approach in peripheral arteries and in this 
form the technique may yet retain a limited role, though its future is 
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otherwise in doubt. Even the use of a thermal feedback control system 
would appear to be unlikely to be able to limit excessive vessel dam-
age. Alternative laser technologies (including the pulsed excimer and 
lensed argon systems) are likely to surpass it though they have still 
to confirm their early promise. Progress in the non-laser based tech-
nologies has come to rival the current laser systems though the likely 
ultimate interventional technique is unknown. A multifibre (for ad-
equate lumen diameter), pulsed (to avoid excess thermal damage), spec-
troscopically and/ or ultrasonically guided laser system would appear to 
be the most taxing technically. If shown to be practical this device 
might still be able to achieve the goal of total laser 
revascularisation that appeared so promising at the beginning of the 
1980s. 
For His bundle ablation the major limitation was inability to deliver 
laser thermal energy precisely to the His bundle despite recording an 
adequate unipolar His bundle electrogram from the tip. This is relevant 
to all percutaneous techniques whatever the energy source: an adequate 
His electrogram does not guarantee proximity of the electrode to the 
endocardial surface. Refinements in the percutaneous approach to en-
hance the delivery of the energy source to the endocardium over the His 
bundle are needed to allow the use of the minimum effective energy. 
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